OVERVIEW OF INFLAMMATION – LOGIC-BASED NOTES

1. Definition & Purpose

Inflammation is a protective response of vascularized tissues to infection and tissue injury.
Its core purpose is to deliver host defense cells and molecules from blood to sites of injury.
Although often perceived as harmful, inflammation is essential for survival.
Without inflammation:

Infections would persist unchecked.
Wounds would not heal.
Injured tissues would remain chronically damaged.

2. What Inflammation Eliminates

Primary cause of injury:

Microbes
Toxins

Consequences of injury:

Necrotic cells
Damaged tissues

Thus, inflammation removes both the insult and its aftermath.

3. Key Defensive Components

Phagocytic leukocytes (e.g., neutrophils, macrophages)
Antibodies
Complement proteins
Most circulate in blood in an inactive, sequestered state:

Prevents damage to normal tissues.
Allows rapid recruitment when needed.

Some immune cells reside in tissues as sentinels, constantly monitoring for danger.

4. Core Function of the Inflammatory Process

Delivers leukocytes and plasma proteins to:

Microbes
Necrotic or damaged tissue

Activates recruited cells and molecules so they:

Destroy harmful agents
Clear dead tissue

This activation is localized, not systemic, under normal control.

5. Sequential Steps of Inflammation (Exam Favorite)

Recognition of offending agent in extravascular tissue.
Recruitment of leukocytes and plasma proteins from blood.
Activation of leukocytes and proteins to eliminate the agent.
Control and termination of the inflammatory response.
Repair of damaged tissue.

6. Types of Inflammation

A. Acute Inflammation

Initial and rapid response.
Onset: minutes to hours.
Duration: hours to a few days.
Main features:

Exudation of fluid and plasma proteins → edema
Emigration of leukocytes, mainly neutrophils

If successful:

Offending agent eliminated
Inflammation subsides
Tissue repair begins

B. Chronic Inflammation

Develops when:

Acute inflammation fails to eliminate the stimulus
Stimulus is persistent

Characterized by:

Prolonged duration
Tissue destruction + repair occurring simultaneously

7. Termination of Inflammation

Occurs when the offending agent is eliminated.
Resolution mechanisms:

Breakdown and dissipation of inflammatory mediators
Short lifespan of leukocytes in tissues
Activation of anti-inflammatory mechanisms

Purpose of termination:

Prevent excessive host damage
Restore tissue homeostasis

8. Tissue Repair After Inflammation

Initiated once elimination is achieved.
Repair involves:

Regeneration of surviving cells
Replacement with connective tissue (scarring) if regeneration is incomplete

Repair is tightly linked to the preceding inflammatory response.

CAUSES OF INFLAMMATION

1. Infections

Most common and clinically important cause.
Includes:

Bacteria
Viruses
Fungi
Parasites

Responses vary from:

Mild, self-limited acute inflammation
Severe systemic inflammation (potentially fatal)
Chronic inflammation with tissue destruction

Morphologic pattern can suggest etiology.

2. Tissue Necrosis

Inflammation occurs regardless of cause of cell death.
Causes include:

Ischemia (e.g., myocardial infarction)
Trauma
Physical injury (burns, frostbite)
Chemical injury
Radiation

Necrotic cells release molecules that directly trigger inflammation.

3. Foreign Bodies

Examples:

Splinters
Dirt
Sutures

Cause inflammation by:

Mechanical tissue injury
Carrying microbes

Endogenous substances can also act as foreign bodies:

Urate crystals → gout
Cholesterol crystals → atherosclerosis

4. Immune Reactions (Hypersensitivity)

Occur when immune responses damage host tissues.
Types:

Autoimmune (against self antigens)
Allergic (against environmental antigens)
Inappropriate responses to microbes

Characteristics:

Stimulus cannot be eliminated
Persistent inflammation
Often chronic
Major cause of morbidity and mortality

RECOGNITION OF MICROBES & DAMAGED CELLS

1. Cellular Receptors for Microbes

Present on:

Phagocytes
Dendritic cells
Epithelial cells

Toll-like receptors (TLRs):

Located on plasma membranes and endosomes
Detect extracellular and ingested microbes
Recognize pathogen-associated molecular patterns (PAMPs)

Activation leads to production of:

Pro-inflammatory cytokines
Anti-viral cytokines (interferons)
Molecules promoting lymphocyte activation

2. Sensors of Cell Damage

Cells detect damage-associated molecular patterns (DAMPs).
Examples of DAMPs:

Uric acid (DNA breakdown)
ATP from damaged mitochondria
Reduced intracellular potassium
Cytoplasmic DNA

These activate the inflammasome, a cytosolic multiprotein complex.
Inflammasome function:

Produces interleukin-1 (IL-1)
IL-1 recruits leukocytes → inflammation

Gain-of-function mutations → autoinflammatory syndromes

Characterized by spontaneous inflammation
Treated with IL-1 antagonists

Inflammasome also involved in:

Gout
Atherosclerosis
Metabolic syndrome
Obesity-associated diabetes
Alzheimer disease

3. Circulating Proteins

Complement system:

Recognizes microbes
Kills microbes
Generates inflammatory mediators

Mannose-binding lectin:

Recognizes microbial sugars
Promotes phagocytosis
Activates complement

Collectins:

Bind microbes
Enhance phagocytosis

ACUTE INFLAMMATION — LOGIC-BASED NOTE (ZERO OMISSION)

1. Core Definition & Purpose

Acute inflammation is the immediate response of vascularized tissues to infection or tissue injury.
Its purpose is to deliver leukocytes and plasma proteins to the site of injury to eliminate the offending agent and remove necrotic tissue.
It is a protective response, essential for survival, even though it often causes tissue damage as a by-product.

2. Three Major Components of Acute Inflammation

Vasodilation of small vessels

Leads to increased blood flow.

Increased microvascular permeability

Allows plasma proteins and leukocytes to exit the circulation.

Leukocyte emigration and activation

Leukocytes leave vessels, accumulate at the injury site, and become activated to eliminate the cause.

3. Sentinel Cell Activation & Mediator Release

Resident tissue phagocytes and sentinel cells detect:

Infectious microbes
Dead or damaged cells

These cells release soluble inflammatory mediators that:

Act locally on blood vessels
Promote plasma leakage
Recruit circulating leukocytes to the injury site

4. Vascular Reactions in Acute Inflammation

Overall Goal

Maximize movement of plasma proteins and leukocytes from blood to tissues.

Key Process: Exudation

Exudation = escape of fluid, proteins, and blood cells into tissues or body cavities.

5. Exudate vs Transudate vs Edema vs Pus

Exudate

High protein concentration
Contains cellular debris
Indicates increased vascular permeability
Typical of inflammation

Transudate

Low protein content
Little or no cellular material
Low specific gravity
Caused by hydrostatic or osmotic imbalance
Occurs with normal vascular permeability

Edema

Excess fluid in interstitial tissues or serous cavities
Can be exudate or transudate

Pus (purulent exudate)

Rich in leukocytes (mainly neutrophils)
Contains dead cells and often microbes

6. Changes in Vascular Flow & Caliber

Step-by-Step Sequence

Vasodilation

Mediated mainly by histamine
Affects arterioles first
Opens new capillary beds
Causes heat and redness (erythema)
May be preceded by brief vasoconstriction

Increased vascular permeability

Protein-rich fluid exits vessels → exudate

Slowing of blood flow (stasis)

Due to:

Fluid loss
Vessel dilation

Leads to:

Concentration of red cells
Increased blood viscosity
Vascular congestion

Leukocyte margination

Neutrophils accumulate along endothelium
Endothelial cells express adhesion molecules
Leukocytes adhere, then migrate out of vessels

7. Mechanisms of Increased Vascular Permeability

1. Endothelial Cell Retraction (Most Common)

Opens interendothelial gaps
Mediated by:

Histamine
Bradykinin
Leukotrienes

Occurs within 15–30 minutes
Short-lived
Called immediate transient response
Predominantly affects postcapillary venules

2. Endothelial Injury

Causes endothelial necrosis and detachment
Seen in:

Severe burns
Microbial or toxin-mediated injury

Neutrophils can worsen injury
Leakage:

Begins immediately
Persists until repair or thrombosis occurs

3. Transcytosis

Increased vesicular transport through endothelial cells
Mediated by intracellular channels
Stimulated by VEGF
Contribution in humans is uncertain

In most injuries, multiple mechanisms operate simultaneously.

8. Lymphatic System Responses

Lymphatics normally drain small amounts of interstitial fluid
During inflammation:

Lymph flow increases to remove edema fluid
Leukocytes, debris, and microbes enter lymph

Lymphatic vessels proliferate
Possible outcomes:

Lymphangitis (inflamed lymphatic vessels)
Lymphadenitis (inflamed lymph nodes)

Inflamed lymph nodes enlarge due to increased cellularity
Red streaks near wounds = lymphangitis
Painful node enlargement = lymphadenitis
Combined changes = reactive (inflammatory) lymphadenitis

9. Leukocyte Recruitment — Overview

Main effector cells:

Neutrophils
Macrophages

Neutrophils:

Rapid responders
Short-lived
Use preformed enzymes

Macrophages:

Slower
Long-lived
Depend on new gene transcription
Produce growth factors for repair

Strong leukocyte activation can cause collateral tissue damage
Systemic inflammation (e.g., bacteremia) can be lethal

10. Multistep Leukocyte Recruitment Process

Margination
Rolling
Firm adhesion
Transmigration (diapedesis)
Chemotaxis

11. Leukocyte Adhesion to Endothelium

Hemodynamic Basis

Slow flow → leukocytes move to vessel periphery
Reduced shear stress enables adhesion

Rolling (Selectins)

Mediated by selectins

E-selectin (endothelium)
P-selectin (platelets & endothelium)
L-selectin (leukocytes)

Ligands = sialylated oligosaccharides
Low-affinity interactions → rolling motion
Selectins are cytokine-induced

Firm Adhesion (Integrins)

Integrins on leukocytes:

Normally low-affinity
Activated by chemokines

Chemokines:

Bind endothelial proteoglycans
Displayed on endothelial surface

Activated integrins bind:

ICAM-1 → LFA-1, Mac-1
VCAM-1 → VLA-4

Results in:

Firm adhesion
Cytoskeletal arrest
Leukocyte immobilization

12. Leukocyte Adhesion Deficiencies

Genetic defects in adhesion molecules cause:

Recurrent bacterial infections
Defective inflammation

Proof of importance of adhesion molecules

13. Transmigration (Diapedesis)

Occurs mainly in postcapillary venules
Leukocytes pass between endothelial cells
Mediated by PECAM-1 (CD31)
Basement membrane crossed using collagenases
Vessel wall usually not damaged

14. Chemotaxis

Directed migration along a chemical gradient
Chemoattractants include:

Bacterial N-formyl peptides
Chemokines
Complement component C5a
Leukotriene LTB4

Act via G-protein–coupled receptors
Trigger actin polymerization:

Actin at leading edge
Myosin at trailing edge

Movement resembles front-wheel drive

15. Temporal Pattern of Cellular Infiltration

0–24 hours: Neutrophils predominate
24–48 hours: Macrophages replace neutrophils
Reasons neutrophils arrive first:

Higher blood concentration
Faster chemokine response
Stronger early adhesion

Exceptions

Pseudomonas infections → prolonged neutrophils
Viral infections → lymphocytes first
Hypersensitivity reactions → lymphocytes, macrophages, plasma cells
Allergic reactions → eosinophils

16. Therapeutic Implications

Molecular understanding enabled targeted therapy
TNF inhibitors:

Highly effective in chronic inflammation

Integrin antagonists:

Reduce leukocyte recruitment

Risk:

Impaired host defense against infections

PHAGOCYTOSIS AND CLEARANCE OF THE OFFENDING AGENT

(Logical Flow Note – Zero Omission)

1. Leukocyte Activation – Why It Happens

Recognition of microbes or dead cells induces a set of responses in leukocytes collectively called leukocyte activation.
After neutrophils and monocytes are recruited to sites of infection or tissue injury, they must be activated to perform effector functions.
Continuous high-level activation would be energy-wasteful and harmful, so activation occurs only when needed.
The most important effector responses for host defense are:

Phagocytosis
Intracellular killing

Additional leukocyte responses aid defense but may also contribute to tissue injury during inflammation.

2. Phagocytosis – The Core Defensive Process

Phagocytosis proceeds through three sequential steps, all triggered by phagocyte activation by microbes, necrotic debris, or inflammatory mediators.

Step 1: Recognition and Attachment

Step 2: Engulfment

Step 3: Killing or Degradation

3. Recognition by Phagocytic Receptors – How Targets Are Identified

3.1 Mannose Receptor

A lectin receptor on macrophages.
Binds terminal mannose and fucose residues on glycoproteins and glycolipids.
These sugars are typical of microbial cell walls.
Mammalian cells instead contain terminal sialic acid or N-acetylgalactosamine.
Therefore, the mannose receptor distinguishes microbes from host cells.

3.2 Scavenger Receptors

Bind and ingest:

Low-density lipoprotein (LDL) particles
A variety of microbes

3.3 Opsonin Receptors (Most Efficient Pathway)

Phagocytosis is greatly enhanced when microbes are opsonized.
Major opsonins:

IgG antibodies
C3b (complement breakdown product)
Plasma lectins, especially mannose-binding lectin

Leukocytes express high-affinity receptors for these opsonins.

4. Engulfment – How Particles Are Internalized

Binding of particles triggers pseudopod extension from the phagocyte.
The plasma membrane flows around the particle.
The membrane pinches off, forming a phagosome.
The phagosome fuses with lysosomes → phagolysosome.
Lysosomal contents are discharged into the phagolysosome.
During this process:

Some granule contents may be released extracellularly
This can cause bystander tissue damage

5. Intracellular Destruction – How Microbes Are Killed

Microbial killing and debris degradation occur via:

Reactive oxygen species (ROS)
Reactive nitrogen species (mainly nitric oxide)
Lysosomal and granule enzymes

All killing mechanisms are:

Sequestered within lysosomes
Prevent damage to phagocyte cytoplasm and nucleus

6. Reactive Oxygen Species (ROS) – Oxygen-Dependent Killing

6.1 Generation of ROS

ROS are produced by phagocyte oxidase (NADPH oxidase).
NADPH oxidase:

Oxidizes NADPH
Reduces oxygen to superoxide anion (O₂•−)

6.2 Respiratory Burst

In neutrophils, ROS generation is tightly linked to phagocytosis.
This rapid oxygen consumption is called the respiratory burst.

6.3 Enzyme Assembly

Phagocyte oxidase consists of ≥7 proteins.
In resting cells:

Some components are in the cytoplasm
Others are in the plasma membrane

Upon activation:

Cytosolic components translocate to the phagosomal membrane
Functional enzyme complex forms there

Result: ROS are produced inside the phagolysosome, sparing host cells.

7. ROS Transformation and Bactericidal Systems

7.1 Hydrogen Peroxide

Superoxide converts to H₂O₂ by spontaneous dismutation.
H₂O₂ alone is not highly bactericidal.

7.2 Myeloperoxidase (MPO) System

Neutrophil azurophilic granules contain myeloperoxidase (MPO).
MPO uses:

H₂O₂
Halides (e.g., Cl⁻)

Produces hypochlorite (OCl⁻) → active ingredient in bleach.
OCl⁻ kills microbes by:

Halogenation of cellular components
Oxidation of proteins and lipids (lipid peroxidation)

H₂O₂–MPO–halide system is the most efficient bactericidal system in neutrophils.
MPO deficiency causes only modest infection susceptibility, showing redundancy in killing mechanisms.

7.3 Hydroxyl Radical

H₂O₂ can also form hydroxyl radical (OH•).
Extremely destructive to lipids, proteins, and nucleic acids.

8. Extracellular ROS and Tissue Injury

ROS may be released extracellularly after:

Microbial exposure
Chemokines
Antigen–antibody complexes
Phagocytic challenge

These ROS contribute to tissue damage in inflammation.

9. Antioxidant Defense Systems

Host protection depends on balance between ROS production and inactivation.

Key Antioxidants:

Superoxide dismutase – converts superoxide to H₂O₂
Catalase – detoxifies H₂O₂
Glutathione peroxidase – detoxifies H₂O₂

10. Clinical Correlation – ROS Deficiency

Defective ROS generation causes chronic granulomatous disease.
Leads to immunodeficiency (covered in Chapter 5).

11. Nitric Oxide (NO) – Nitrogen-Dependent Killing

11.1 NO Synthesis

NO is produced from arginine by nitric oxide synthase (NOS).
Three NOS types:

eNOS – endothelial, vascular tone
nNOS – neuronal, neurotransmission
iNOS – inducible, microbial killing

11.2 iNOS in Macrophages

Expressed after activation by:

Cytokines (e.g., IFN-γ)
Microbial products

Produces large amounts of NO.

11.3 Peroxynitrite Formation

NO reacts with superoxide → peroxynitrite (ONOO•).
Peroxynitrite damages:

Lipids
Proteins
Nucleic acids

Affects microbes and host cells.

11.4 Vascular Effects of NO

Endothelial NO causes vasodilation via smooth muscle relaxation.
Its role in acute inflammatory vascular reactions remains uncertain.

12. Granule Enzymes and Antimicrobial Proteins

12.1 Granule Characteristics

Granules are actively secretory, not classical lysosomes.
Present in neutrophils and monocytes.
Destroy microbes and dead tissue but can cause collateral tissue injury.

13. Neutrophil Granule Types

13.1 Specific (Secondary) Granules

Contain:

Lysozyme
Collagenase
Gelatinase
Lactoferrin
Plasminogen activator
Histaminase
Alkaline phosphatase

13.2 Azurophil (Primary) Granules

Contain:

Myeloperoxidase (MPO)
Defensins
Acid hydrolases
Neutral proteases:

Elastase
Cathepsin G
Nonspecific collagenases
Proteinase 3

14. Granule Function and Tissue Injury

Granules fuse with phagosomes to destroy ingested material.
Both granule types can undergo degranulation → extracellular enzyme release.
Acid proteases act within phagolysosomes.
Neutral proteases degrade extracellular matrix:

Collagen
Basement membrane
Fibrin
Elastin
Cartilage

These processes cause inflammatory tissue destruction.

15. Macrophage Enzymes

Macrophages contain:

Acid hydrolases
Collagenase
Elastase
Phospholipase
Plasminogen activator

16. Protease Regulation

Protease activity is controlled by anti-proteases in serum and tissues.
α1-antitrypsin:

Major inhibitor of neutrophil elastase

Deficiency leads to uncontrolled protease activity
Seen in α1-antitrypsin deficiency (Chapter 13)

17. Neutrophil Extracellular Traps (NETs)

17.1 What NETs Are

Extracellular fibrillar networks that:

Trap microbes
Concentrate antimicrobial substances
Prevent microbial spread

17.2 Composition

Viscous meshwork of nuclear chromatin
Binds granule proteins:

Antimicrobial peptides
Enzymes

17.3 Formation and Function

Produced in response to:

Bacteria
Fungi
Chemokines
Cytokines
Complement proteins

Provide microbial killing without phagocytosis.

17.4 NETosis

NET formation leads to loss of neutrophil nuclei.
Results in cell death → called NETosis.
Distinct from apoptosis and necrosis.

18. NETs and Disease

NETs detected in blood during sepsis.
Nuclear chromatin (DNA + histones) in NETs:

Acts as a source of nuclear antigens
Contributes to systemic autoimmune diseases, especially lupus.

Leukocyte-Mediated Tissue Injury

Why leukocytes can injure normal tissues

Leukocytes are essential for host defense, but their weapons are non-selective. When activated intensely or inappropriately, the same mechanisms that kill microbes can damage host tissues.

Circumstances where leukocyte injury occurs

1. Collateral damage during normal host defense

During infections, leukocytes attack microbes using toxic enzymes, reactive oxygen species (ROS), and nitric oxide.
Surrounding host tissues are exposed to these mediators.
In chronic or hard-to-eradicate infections (e.g., tuberculosis, chronic viral hepatitis):

The host inflammatory response contributes more to tissue damage than the microbe itself.

Logic: Persistent stimulus → prolonged leukocyte activation → cumulative tissue injury.

Exam hook:

In chronic infections, pathology often reflects immune-mediated injury, not direct microbial cytotoxicity.

2. Autoimmune inflammation

The inflammatory response is misdirected against self-antigens.
Leukocytes recognize host tissues as targets.
Continuous activation leads to progressive tissue destruction.

Logic: Loss of self-tolerance → leukocyte activation against host → chronic inflammation → organ damage.

3. Hypersensitivity (allergic) reactions

Exaggerated immune response to normally harmless antigens.
Includes:

Asthma
Drug reactions
Other allergic diseases

Leukocytes release mediators that cause bronchoconstriction, edema, epithelial damage.

Logic: Harmless antigen → hyper-reactive immune response → inappropriate leukocyte activation → tissue injury.

How leukocytes cause tissue damage

Core mechanism: Release of injurious molecules

Leukocytes damage tissues primarily by extracellular release of toxic granule contents.

Mechanisms of granule release

1. Controlled degranulation (physiologic)

Occurs after leukocyte activation.
Granule contents are released in a regulated manner.
Normally helps destroy microbes.

Risk: Spillover of enzymes damages nearby host tissues.

2. Frustrated phagocytosis (high-yield concept)

Occurs when leukocytes encounter targets they cannot engulf.
Classic example:

Immune complexes deposited on flat, immovable surfaces (e.g., glomerular basement membrane).

Leukocytes attempt phagocytosis but fail.
Result:

Intense activation
Massive extracellular release of lysosomal enzymes and ROS

Logic:

Unable to ingest target → persistent activation → extracellular enzyme dumping → severe tissue injury.

Exam hook:

Frustrated phagocytosis explains tissue injury in immune complex–mediated diseases (e.g., glomerulonephritis).

3. Phagolysosomal membrane damage

Some ingested substances injure the phagolysosome membrane.
Examples:

Urate crystals (gout)
Silica crystals

Leads to leakage of:

Proteases
ROS

Into cytoplasm and extracellular space.

Logic: Crystal ingestion → lysosomal rupture → enzyme release → inflammation and tissue injury.

Other Functional Responses of Activated Leukocytes

Activated leukocytes do more than kill microbes.

Cytokine production

Especially by macrophages.
Cytokines can:

Amplify inflammation (e.g., TNF, IL-1)
Limit inflammation (e.g., IL-10, TGF-β)

Logic: Macrophages regulate the intensity and duration of inflammation.

Growth factor secretion

Stimulate:

Endothelial cell proliferation
Fibroblast proliferation
Collagen synthesis

Role: Tissue repair and angiogenesis after injury.

Extracellular matrix remodeling

Enzymes degrade and reorganize connective tissue.
Essential for:

Resolution of inflammation
Scar formation

Role in chronic inflammation and repair

Macrophages are central coordinators of:

Chronic inflammation
Healing and fibrosis

They link inflammation → repair → remodeling.

Role of T Lymphocytes in Acute Inflammation

Although acute inflammation is classically driven by neutrophils and macrophages, adaptive immune cells also contribute.

TH17 cells (exam-relevant)

Subset of T lymphocytes.
Secrete IL-17.

Actions of IL-17

Induces secretion of chemokines.
Chemokines recruit:

Neutrophils
Other leukocytes

Logic:

TH17 activation → IL-17 release → chemokine production → leukocyte recruitment.

Clinical relevance of defective TH17 responses

Increased susceptibility to:

Fungal infections
Bacterial infections

Abscesses formed are:

“Cold abscesses”
Lack classic signs of acute inflammation:

Warmth
Redness

Exam hook:

Absence of IL-17 → poor neutrophil recruitment → blunted acute inflammatory signs.

Termination of the Acute Inflammatory Response

Inflammation is potentially destructive, so it must be actively shut down.

Passive mechanisms (stimulus-dependent)

1. Short half-life of mediators

Inflammatory mediators are:

Produced in bursts
Rapidly degraded

2. Removal of the inciting stimulus

Once microbes or necrotic tissue are eliminated:

Mediator production stops

3. Neutrophil apoptosis

Neutrophils:

Have short tissue life span
Undergo apoptosis within hours to 1–2 days

Active termination mechanisms (high-yield)

1. Lipid mediator switching

Arachidonic acid metabolism shifts from:

Pro-inflammatory leukotrienes
To anti-inflammatory lipoxins

Logic: Same pathway → different products → inflammation off-switch.

2. Anti-inflammatory cytokines

Released from macrophages and other cells.
Key cytokines:

TGF-β
IL-10

Functions:

Suppress leukocyte activation
Inhibit cytokine production

3. Neural regulation

Cholinergic neural impulses:

Inhibit TNF production by macrophages

Logic: Nervous system provides systemic control over inflammation.

One-Line Exam Summary

Leukocyte-mediated tissue injury results from excessive or inappropriate activation of leukocytes, causing extracellular release of toxic mediators, while resolution of inflammation requires both passive decay of mediators and active anti-inflammatory mechanisms including lipid mediator switching, cytokines, and neural inhibition.

MEDIATORS OF INFLAMMATION (Concept + Big Picture)

Mediators of inflammation are substances that initiate and regulate inflammatory reactions.
The long list matters clinically because it has directly enabled development of many everyday anti-inflammatory drugs (examples explicitly noted: aspirin and acetaminophen).
The most important mediators of acute inflammation are:

Vasoactive amines
Lipid products (prostaglandins and leukotrienes)
Cytokines (including chemokines)
Products of complement activation (as referenced with Table 3.5)

The text first gives general properties of mediators, then details key molecules.
GENERAL PROPERTIES OF INFLAMMATORY MEDIATORS (Rules that make the system “controlled”)

Where mediators come from (local vs plasma)

Mediators may be produced locally by cells at the site of inflammation OR derived from circulating inactive precursors that are activated at the site.
Cell-derived mediators are either:

Rapidly released from intracellular granules (example: amines), OR
Synthesized de novo (examples: prostaglandins, leukotrienes, cytokines) in response to a stimulus.

The major cell types producing mediators of acute inflammation are:

Tissue macrophages
Dendritic cells
Mast cells

Additional cells that also can be induced to produce some mediators include:

Platelets
Neutrophils
Endothelial cells
Most epithelia

Therefore, cell-derived mediators are most important for reactions against offending agents in tissues.
Plasma-derived mediators (example: complement proteins) are:

Present in the circulation as inactive precursors
Must be activated (usually by a series of proteolytic cleavages) to acquire biologic activity
Produced mainly in the liver
Effective against circulating microbes
Also can be recruited into tissues

When they are produced

Active mediators are produced only in response to molecules that stimulate inflammation, including:

Microbial products
Substances released from necrotic cells

Many stimuli trigger well-defined receptors and signaling pathways (as described earlier in the chapter).
The requirement for microbes or dead tissues as initiating stimuli ensures inflammation is normally triggered only when and where needed.

How long they last

Most mediators are short-lived.
They are rapidly terminated by:

Decay
Enzymatic inactivation
Being scavenged
Being inhibited

This creates checks and balances regulating mediator actions (and these control mechanisms are discussed with each mediator class).

Amplification and cross-talk

One mediator can stimulate release of other mediators.
Examples explicitly given:

Complement activation products stimulate histamine release.
TNF acts on endothelial cells to stimulate production of IL-1 and many chemokines.

Secondary mediators may:

Have the same actions as initial mediators, OR
Have different or even opposing actions.

This provides mechanisms for:

Amplifying mediator effects, OR
In some instances counteracting the initial mediator action.

VASOACTIVE AMINES: HISTAMINE AND SEROTONIN (Fast, preformed vessel-active mediators)

The two major vasoactive amines are histamine and serotonin.
They are called vasoactive because they have important actions on blood vessels.
They are stored as preformed molecules in cells, so they are among the first mediators released during inflammation.

HISTAMINE (Sources, triggers, effects, receptors, drug relevance)

Major sources of histamine

Richest sources: mast cells in connective tissue adjacent to blood vessels.
Also found in:

Blood basophils
Platelets

Storage and release

Histamine is stored in mast cell granules.
It is released by degranulation in response to multiple stimuli.

Stimuli that trigger histamine release (explicit list)

Physical injury such as:

Trauma
Cold
Heat
Mechanism for these physical triggers is stated as unknown.

Binding of antibodies to mast cells, underlying immediate hypersensitivity (allergic) reactions (noted to be in Chapter 5).
Complement products called anaphylatoxins:

C3a
C5a
(Noted as described later.)

Mechanism detail: antibodies and complement products bind to specific receptors on mast cells and trigger signaling pathways causing rapid degranulation.
Additional triggers noted:

Neuropeptides (example: substance P)
Cytokines (IL-1, IL-8)

Vascular effects of histamine (key acute permeability role)

Causes dilation of arterioles.
Increases permeability of venules.
Considered the principal mediator of the immediate transient phase of increased vascular permeability.
Mechanism described: produces interendothelial gaps in postcapillary venules (as discussed earlier).

Receptor mechanism

Vasoactive effects mediated mainly via binding to H1 receptors on microvascular endothelial cells.

Drug connection

Common antihistamine drugs used to treat some inflammatory reactions (example: allergies) are H1 receptor antagonists that bind to and block the receptor.

Smooth muscle effect (and comparison to leukotrienes)

Histamine can cause contraction of some smooth muscles.
But leukotrienes are stated to be much more potent and more relevant for bronchial muscle spasms, such as in asthma.

SEROTONIN (5-HT) (Where found, main function, vascular note)

Serotonin (5-hydroxytryptamine) is a preformed vasoactive mediator found in:

Platelets
Certain neuroendocrine cells (example given: in the gastrointestinal tract)
Mast cells in rodents but not humans

Its primary function is as a neurotransmitter in the gastrointestinal tract.
It is also a vasoconstrictor, but its importance in inflammation is stated as unclear.

ARACHIDONIC ACID METABOLITES (Eicosanoids): PROSTAGLANDINS, LEUKOTRIENES, LIPOXINS

Core idea

Lipid mediators prostaglandins and leukotrienes come from arachidonic acid in membrane phospholipids.
They stimulate vascular and cellular reactions in acute inflammation.

What arachidonic acid is and where it comes from

Arachidonic acid is a 20-carbon polyunsaturated fatty acid.
Derived from:

Dietary sources, OR
Conversion from essential fatty acid linoleic acid

Most cellular arachidonic acid is:

Esterified
Incorporated into membrane phospholipids

How it is released

Mechanical, chemical, and physical stimuli, or other mediators (example: C5a) trigger release of arachidonic acid from membranes by activating cellular phospholipases, mainly phospholipase A2.

What happens after release

Once freed from the membrane, arachidonic acid is rapidly converted to bioactive mediators.

Eicosanoids (definition + naming logic)

These mediators are called eicosanoids because they are derived from 20-carbon fatty acids (Greek eicosa = 20).

Two key enzyme classes (pathways)

Synthesized by:

Cyclooxygenases → generate prostaglandins
Lipoxygenases → produce leukotrienes and lipoxins

(Referenced to Fig. 3.9.)

Receptors and breadth of action

Eicosanoids bind to G protein-coupled receptors on many cell types.
They can mediate virtually every step of inflammation (referenced to Table 3.6).

PROSTAGLANDINS (Sources, COX biology, key PGs, actions)

Sources

Produced by:

Mast cells
Macrophages
Endothelial cells
Many other cell types

Role

Involved in vascular and systemic reactions of inflammation.

COX enzymes

Generated by actions of two cyclooxygenases:

COX-1
COX-2

COX-1

Produced in response to inflammatory stimuli AND is constitutively expressed in most tissues.
May serve homeostatic functions, explicitly including:

Fluid and electrolyte balance in the kidneys
Cytoprotection in the gastrointestinal tract

COX-2

Induced by inflammatory stimuli
Generates PGs involved in inflammatory reactions
Low or absent in most normal tissues

Prostaglandin naming

Named by:

A letter coding structural features (examples listed: PGD, PGE, PGF, PGG, PGH)
A subscript numeral (e.g., 1, 2) indicating the number of double bonds

Most important prostaglandins in inflammation (explicit list)

PGE2
PGD2
PGF2α
PGI2 (prostacyclin)
TXA2 (thromboxane A2)
Each derived by action of a specific enzyme on an intermediate in the pathway.
Some enzymes have restricted tissue distribution and functions.

Functional breakdown (explicit bullet set preserved)

PGD2

Major prostaglandin made by mast cells.
Along with PGE2 (more widely distributed), causes:

Vasodilation
Increased permeability of postcapillary venules
Potentiates exudation and resulting edema

Also a chemoattractant for neutrophils

TXA2

Platelets contain thromboxane synthase, which synthesizes TXA2 (the major platelet eicosanoid).
TXA2 is a potent:

Platelet-aggregating agent
Vasoconstrictor

Therefore promotes thrombosis

PGI2 (prostacyclin)

Vascular endothelium contains prostacyclin synthase, responsible for forming prostacyclin (PGI2) and its stable end product PGF1α.
Prostacyclin is:

A vasodilator
A potent inhibitor of platelet aggregation

Thus prevents thrombus formation on normal endothelial cells
A thromboxane–prostacyclin imbalance has been implicated in coronary and cerebral artery thrombosis (noted as Chapter 4).

Pain and fever roles

Prostaglandins also contribute to pain and fever, common systemic manifestations.
PGE2

Makes skin hypersensitive to painful stimuli
Causes fever during infections (described later)

LEUKOTRIENES (Sources, synthesis flow, key leukotrienes, actions)

Produced in leukocytes and mast cells by lipoxygenase.
Involved in:

Vascular reactions
Smooth muscle reactions
Leukocyte recruitment

Synthesis outline

Multi-step synthesis begins with generating LTA4.
LTA4 then gives rise to:

LTB4 OR
LTC4

LTB4

Produced by neutrophils and some macrophages.
Potent chemotactic agent and activator of neutrophils.
Causes:

Aggregation and adhesion of cells to venular endothelium
Generation of ROS
Release of lysosomal enzymes

Cysteinyl leukotrienes: LTC4, LTD4, LTE4

LTC4 and its metabolites LTD4 and LTE4 produced mainly in mast cells.
Cause:

Intense vasoconstriction
Bronchospasm (explicitly important in asthma)
Increased permeability of venules

LIPOXINS (Anti-inflammatory eicosanoids + special biosynthesis requirement)

Generated from arachidonic acid via the lipoxygenase pathway.
Unlike prostaglandins and leukotrienes, lipoxins suppress inflammation by inhibiting leukocyte recruitment.
They inhibit:

Neutrophil chemotaxis
Neutrophil adhesion to endothelium

Transcellular biosynthesis (explicit “two-cell” requirement)

Requires two cell populations.
Leukocytes, especially neutrophils, produce intermediates.
These intermediates are converted to lipoxins by platelets interacting with leukocytes.

PHARMACOLOGIC INHIBITORS OF PROSTAGLANDINS AND LEUKOTRIENES (Why targets matter + exact drug logic)

Because eicosanoids are central in inflammation, drugs have been designed to inhibit their production or actions to suppress inflammation.
Cyclooxygenase inhibitors

Include:

Aspirin
Other NSAIDs such as ibuprofen

They inhibit both COX-1 and COX-2 → block all prostaglandin synthesis.
This explains their efficacy in treating pain and fever.
Aspirin irreversibly inactivates cyclooxygenases.
Selective COX-2 inhibitors

Newer class; 200- to 300-fold more potent in blocking COX-2 than COX-1.
Rationale of interest:

COX-1 may produce prostaglandins involved in inflammation and also normal protective functions like gastric epithelial protection from acid injury.
COX-2 generates prostaglandins involved only in inflammation.

Predicted advantage (if rationale held perfectly): anti-inflammatory effects without toxicities like gastric ulceration.
Caveats explicitly stated:

Distinctions are not absolute because COX-2 also contributes to some normal homeostasis.
Selective COX-2 inhibitors may increase risk of cardiovascular and cerebrovascular events.
Proposed mechanism for this risk:

They impair endothelial PGI2 (prostacyclin) production (anti-thrombotic)
While leaving intact platelet COX-1–mediated TXA2 production (pro-aggregation)

Net effect: tilts balance toward vascular thrombosis, especially with other thrombosis risk factors.

Clinical use statement:

Used in individuals without cardiovascular risk factors and when benefits outweigh risks.

Lipoxygenase inhibitors

5-lipoxygenase is not affected by NSAIDs.
Many inhibitors of this pathway have been developed.
Example given: inhibitors that reduce leukotriene production such as zileuton.
Use: useful in treatment of asthma.

Corticosteroids (broad spectrum)

Reduce transcription of genes encoding:

COX-2
Phospholipase A2
Proinflammatory cytokines (examples: IL-1, TNF)
iNOS

Leukotriene receptor antagonists

Block leukotriene receptors and prevent leukotriene actions.
Example given: Montelukast
Use: useful in treatment of asthma.

CYTOKINES AND CHEMOKINES (Protein mediators that coordinate leukocyte recruitment + systemic effects)

Cytokines are proteins secreted by many cell types that mediate and regulate immune and inflammatory reactions.
Main producing cells listed:

Activated lymphocytes
Macrophages
Dendritic cells

Also produced by:

Endothelial cells
Epithelial cells
Connective tissue cells

By convention, growth factors acting on epithelial and mesenchymal cells are not grouped under cytokines.
Cytokines in acute inflammation are reviewed here (referenced as Table 3.7).

TNF AND IL-1 (Core recruitment cytokines + endothelial activation + systemic illness logic)

Central role

TNF and IL-1 are critical for leukocyte recruitment by promoting:

Adhesion of leukocytes to endothelium
Migration through vessels

Major sources

Mainly produced by activated macrophages and dendritic cells.
TNF also produced by:

T lymphocytes
Mast cells

Some epithelial cells also produce IL-1.

Stimuli that induce TNF and IL-1

Microbial products
Foreign bodies
Necrotic cells
A variety of other inflammatory stimuli

Mechanistic note on induction

TNF production induced by signals through TLRs and other microbial sensors.
IL-1 synthesis stimulated by similar signals, but generation of biologically active IL-1 depends on the inflammasome (described earlier).

Actions (local + systemic) (referenced to Fig. 3.10)

Endothelial activation (explicit definition components)

TNF and IL-1 induce a spectrum called endothelial activation, including:

Increased expression of endothelial adhesion molecules, mostly:

E-selectins
P-selectins
Ligands for leukocyte integrins

Increased production of mediators including:

Other cytokines
Chemokines
Eicosanoids

Increased procoagulant activity of endothelium

Activation of leukocytes and other cells

TNF

Augments neutrophil responses to other stimuli such as bacterial endotoxin
Stimulates microbicidal activity of macrophages

IL-1

Activates fibroblasts to synthesize collagen
Stimulates proliferation of synovial cells and other mesenchymal cells

IL-1 and IL-6

Stimulate generation of TH17 subset of CD4+ helper T cells (described later and in Chapter 5)

Systemic acute-phase response

IL-1 and TNF (as well as IL-6) induce systemic acute-phase responses associated with infection or injury, including fever (described later).
They are also implicated in SIRS (systemic inflammatory response syndrome) due to:

Disseminated bacterial infection (sepsis)
Other serious conditions (described later)

Energy balance and cachexia

TNF regulates energy balance by:

Promoting lipid and protein catabolism
Suppressing appetite

Sustained TNF production contributes to cachexia, characterized by:

Weight loss
Muscle atrophy
Anorexia

Cachexia accompanies some chronic infections and cancers.

Therapeutic blockade note

TNF antagonists are remarkably effective in chronic inflammatory diseases, especially:

Rheumatoid arthritis
Psoriasis
Some types of inflammatory bowel disease

Complication of TNF antagonist therapy:

Increased susceptibility to mycobacterial infection due to reduced macrophage ability to kill intracellular microbes.

Although TNF and IL-1 actions overlap, IL-1 antagonists are not as effective (reason stated as obscure).
Blocking either TNF or IL-1 has no effect on sepsis outcome, possibly because other cytokines also contribute to this systemic reaction.

CHEMOKINES (Classification, receptors, endothelial display, two big functions)

Definition

Chemokines are small proteins (8–10 kD) that act primarily as chemoattractants for specific leukocytes.

Scale

About 40 chemokines and 20 receptors have been identified.

Four major groups (based on cysteine arrangement)

C-X-C chemokines

One amino acid separates the first two of four conserved cysteines.
Act primarily on neutrophils.
Example: IL-8 (CXCL8).
CXCL8 is secreted by:

Activated macrophages
Endothelial cells
Other cell types

CXCL8 causes:

Activation and chemotaxis of neutrophils
Limited activity on monocytes and eosinophils

Most important inducers:

Microbial products
Cytokines mainly IL-1 and TNF

C-C chemokines

First two conserved cysteine residues are adjacent.
Include:

MCP-1 (CCL2)
Eotaxin (CCL11)
MIP-1α (CCL3)

Mainly chemoattractants for:

Monocytes
Eosinophils
Basophils
Lymphocytes

Many have overlapping actions, but eotaxin selectively recruits eosinophils.

C chemokines

Lack the first and third of the four conserved cysteines.
Example: lymphotactin (XCL1)
Relatively specific for lymphocytes

CX3C chemokines

Contain three amino acids between the first two cysteines.
Only known member: fractalkine (CX3CL1)
Exists in two forms:

Cell surface-bound protein induced on endothelial cells by inflammatory cytokines that promotes strong adhesion of monocytes and T cells
Soluble form derived by proteolysis of membrane-bound protein that has potent chemoattractant activity for the same cells

Chemokine receptors

Chemokines bind seven-transmembrane G protein-coupled receptors.
Receptors have overlapping ligand specificities, and leukocytes usually express multiple receptors.
Certain chemokine receptors (CXCR4, CCR5) act as coreceptors for an HIV envelope glycoprotein → involved in binding and entry of HIV into cells (AIDS linkage noted, with Chapter 5 reference).

How chemokines are positioned for function

Chemokines bind to proteoglycans and are displayed at high concentrations on:

Endothelial cell surfaces
Extracellular matrix

Two main functions (explicit)

Acute inflammation

Stimulate leukocyte attachment to endothelium by acting on leukocytes to increase integrin affinity
Serve as chemoattractants, guiding leukocytes to infection/tissue damage sites
Because they mediate inflammatory reaction aspects, called inflammatory chemokines
Production induced by microbes and other stimuli

Maintenance of tissue architecture

Some chemokines produced constitutively by stromal cells → called homeostatic chemokines
Organize cells in different anatomic tissue regions, e.g. T and B lymphocytes in discrete spleen and lymph node areas (Chapter 5)

Drug development challenge

Despite established role, developing chemokine antagonists has been difficult, possibly due to functional redundancy.

OTHER CYTOKINES IN ACUTE INFLAMMATION (Named additions + therapeutic notes)

The cytokine list is described as huge and constantly growing.
Two highlighted besides earlier ones:

IL-6

Made by macrophages and other cells
Involved in local and systemic reactions
IL-6 receptor antagonists are used in rheumatoid arthritis

IL-17

Produced mainly by T lymphocytes
Promotes neutrophil recruitment
IL-17 antagonists are very effective in psoriasis and other inflammatory diseases

Type I interferons

Normal function: inhibit viral replication
They contribute to some systemic manifestations of inflammation

Cytokines also play key roles in chronic inflammation, which are described later in the chapter.

COMPLEMENT SYSTEM — LOGIC-BASED NOTE (ZERO OMISSION)

1. What the Complement System Is

The complement system is a collection of soluble plasma proteins and membrane receptors.
It functions mainly in:

Host defense against microbes
Pathologic inflammatory reactions

It consists of more than 20 proteins, many named C1–C9.
Complement participates in both innate and adaptive immunity.
During activation, cleavage products are generated that cause:

Increased vascular permeability
Chemotaxis
Opsonization

2. General Mechanism of Complement Activation

Complement proteins circulate in inactive forms in plasma.
Upon activation:

They become proteolytic enzymes
Each activated enzyme cleaves the next component

This creates an enzymatic cascade with tremendous amplification.
Critical step in complement activation:

Proteolysis of C3, the most abundant complement protein

3. Pathways of Complement Activation (All Converge at C3)

Cleavage of C3 can occur by three pathways:

A. Classical Pathway

Triggered by C1 binding to antibody
Antibodies involved:

IgM
IgG

Antibody must already be bound to antigen

B. Alternative Pathway

Triggered without antibody
Activated by:

Microbial surface molecules (e.g. endotoxin / LPS)
Complex polysaccharides
Other microbial substances

C. Lectin Pathway

Initiated when mannose-binding lectin (MBL) binds to carbohydrates on microbes
This binding directly activates C1

4. Central Enzymes and Amplification

All three pathways generate C3 convertase
C3 convertase cleaves C3 → C3a + C3b

C3a:

Released into the circulation

C3b:

Covalently attaches to the microbial or target surface

Additional C3b molecules bind to form C5 convertase
C5 convertase cleaves C5 → C5a + C5b

C5a: released
C5b: remains cell-bound

C5b binds C6–C9, forming the Membrane Attack Complex (MAC)
MAC consists of multiple C9 molecules
Amplification is extreme:

Millions of C3b molecules can deposit on a microbe within 2–3 minutes

5. Major Functions of Complement (Three Core Outcomes)

A. Inflammation

C5a (most potent), and to a lesser extent C4a and C3a, are:

Anaphylatoxins

Actions:

Stimulate histamine release from mast cells
Cause:

Increased vascular permeability
Vasodilation

Called anaphylatoxins because they mimic mediators of anaphylaxis
C5a also:

Acts as a chemotactic factor for:

Neutrophils
Monocytes
Eosinophils
Basophils

Activates the lipoxygenase pathway of arachidonic acid metabolism
Causes release of additional inflammatory mediators

B. Opsonization and Phagocytosis

C3b and iC3b (inactive C3b) bind microbial cell walls
They act as opsonins
Phagocytosis occurs via:

Neutrophils
Macrophages

These cells express receptors for C3 fragments

C. Cell Lysis

MAC inserts into cell membranes
Creates pores, increasing permeability to:

Water
Ions

Leads to osmotic lysis
Most important for microbes with thin cell walls, especially:

Neisseria species

Deficiency of terminal complement components predisposes to:

Neisseria meningococci
Neisseria gonococci

In these patients, infections can become severe and disseminated

6. Regulation of the Complement System

Complement activation is tightly controlled
Regulation is achieved by:

Cell-associated proteins
Circulating regulatory proteins

Functions of regulators:

Inhibit formation of active complement fragments
Remove deposited complement fragments

These proteins are expressed on normal host cells
Purpose:

Prevent injury to healthy tissues

Regulation can be overwhelmed in:

Autoimmune diseases
Presence of complement-fixing autoantibodies

7. Key Complement Regulatory Proteins and Diseases

A. C1 Inhibitor

Blocks activation of C1
Deficiency causes:

Hereditary angioedema

B. Decay Accelerating Factor (DAF) and CD59

Both are attached to membranes via GPI anchors
DAF:

Prevents formation of C3 convertases

CD59:

Inhibits MAC formation

Deficiency of GPI anchor synthesis enzyme causes:

Loss of DAF and CD59
Excessive complement activation
Red cell lysis

Resulting disease:

Paroxysmal nocturnal hemoglobinuria (PNH)

C. Factor H

Plasma protein
Acts as a cofactor for proteolytic inactivation of C3 convertase
Deficiency leads to:

Excessive complement activation

Associated diseases:

Hemolytic uremic syndrome
Wet macular degeneration (via increased retinal vascular permeability)

8. Complement in Disease

Complement causes injury when activated by:

Antibodies
Antigen–antibody complexes deposited on host tissues

Leads to:

Cell and tissue injury

Inherited complement deficiencies:

Increase susceptibility to infections

Regulatory protein deficiencies:

Cause diverse inflammatory and hemolytic disorders

OTHER MEDIATORS OF INFLAMMATION

9. Platelet-Activating Factor (PAF)

Phospholipid-derived mediator
Initially identified as a platelet aggregation factor
Produced by:

Platelets
Basophils
Mast cells
Neutrophils
Macrophages
Endothelial cells

Actions:

Platelet aggregation
Vasoconstriction
Bronchoconstriction
At low concentrations:

Vasodilation
Increased vascular permeability

Clinical trials of PAF antagonists:

Have been disappointing

10. Products of Coagulation

Historical observation:

Inhibiting coagulation reduced inflammation

Discovery of Protease-Activated Receptors (PARs) supported this link
Thrombin activates PARs
PARs expressed on:

Leukocytes
Platelets

Clearest role:

Platelet aggregation via thrombin receptor

Clotting and inflammation are closely linked because:

Tissue injury → clotting + inflammation
Inflammation alters endothelium → promotes thrombosis

Whether coagulation products directly stimulate inflammation:

Still not firmly established

11. Kinins

Vasoactive peptides
Derived from kininogens
Generated by kallikreins
Kallikrein cleaves high-molecular-weight kininogen → bradykinin
Bradykinin effects:

Increased vascular permeability
Smooth muscle contraction
Vasodilation
Pain

Actions resemble histamine
Rapidly inactivated by:

Kininase

Implicated in:

Allergic reactions
Anaphylaxis

12. Neuropeptides

Secreted by:

Sensory nerves
Leukocytes

Examples:

Substance P
Neurokinin A

Produced in:

Central nervous system
Peripheral nervous system

High concentrations in:

Lung
Gastrointestinal tract

Functions of substance P:

Pain transmission
Blood pressure regulation
Hormone secretion
Increased vascular permeability

13. Final Integration

Early inflammatory research thought histamine alone was sufficient
Now many mediators are known
Despite redundancy:

A few mediators dominate acute inflammation

Redundancy ensures:

Robust host defense
Resistance to failure if one pathway is blocked

Clinical relevance is confirmed by:

Effectiveness of anti-inflammatory antagonists

This demonstrates the direct link between basic biology and medicine

MORPHOLOGIC PATTERNS OF ACUTE INFLAMMATION

Core Morphologic Hallmarks (What always happens)

Acute inflammation is defined morphologically by dilation of small blood vessels and accumulation of leukocytes and fluid in extravascular tissue.
These vascular and cellular reactions directly explain the classical signs and symptoms of inflammation.

Vascular changes → clinical signs

Increased blood flow + increased vascular permeability →

Extravascular fluid rich in plasma proteins (edema)
Causes:

Redness (rubor)
Warmth (calor)
Swelling (tumor)

Cellular changes → tissue injury and symptoms

Recruited and activated leukocytes release:

Toxic metabolites
Proteases

These are released extracellularly, leading to:

Tissue damage
Loss of function (functio laesa)

Pain mechanism

Pain (dolor) arises due to:

Tissue damage itself
Liberation of prostaglandins
Release of neuropeptides
Release of cytokines

Why Morphologic Patterns Matter

Although these general features are common to most acute inflammatory reactions:

Specific morphologic patterns are superimposed depending on:

Severity of reaction
Specific cause
Tissue type
Anatomic site

Recognizing distinct gross and microscopic patterns:

Provides valuable clues to the underlying cause

SPECIFIC MORPHOLOGIC PATTERNS

1. Serous Inflammation

Definition

Characterized by exudation of cell-poor fluid into:

Spaces created by injury to surface epithelia
Body cavities lined by:

Peritoneum
Pleura
Pericardium

Nature of fluid

Typically:

Not infected by destructive organisms
Low leukocyte content

High leukocyte content would instead produce purulent inflammation

Source of fluid in body cavities

May come from:

Plasma (due to increased vascular permeability)
Mesothelial cell secretions (due to local irritation)

Terminology

Accumulation of serous fluid in body cavities = effusion

Important distinction

Transudative effusions also occur in non-inflammatory conditions, such as:

Reduced blood outflow (e.g., heart failure)
Reduced plasma protein levels (e.g., kidney or liver disease)

Classic example

Skin blister from:

Burns
Viral infections

Represents accumulation of serous fluid:

Within
Or immediately beneath
The damaged epidermis

2. Fibrinous Inflammation

When it occurs

Develops when:

Vascular leaks are large
OR there is a local procoagulant stimulus

Pathogenesis

Large increase in vascular permeability allows:

High-molecular-weight proteins (e.g., fibrinogen) to escape

Fibrinogen is converted to fibrin, which deposits in:

Extracellular space

Typical locations

Lining of body cavities, especially:

Meninges
Pericardium
Pleura

Histologic appearance

Fibrin appears as:

Eosinophilic meshwork of threads
Or amorphous coagulum

Fate of fibrin

May be:

Dissolved by fibrinolysis
Cleared by macrophages

If not removed:

Stimulates ingrowth of:

Fibroblasts
Blood vessels

Leads to scarring (organization)

Clinical consequence example

In the pericardium:

Organization → fibrous thickening of:

Pericardium
Epicardium

Extensive fibrosis →

Obliteration of the pericardial space

3. Purulent (Suppurative) Inflammation and Abscess

Definition

Characterized by production of pus, consisting of:

Neutrophils
Liquefied debris of necrotic cells
Edema fluid

Common cause

Infection with bacteria that cause:

Liquefactive necrosis

Classic organisms:

Staphylococci

Such organisms are termed pyogenic (pus-producing) bacteria

Example

Acute appendicitis is a classic acute suppurative inflammation

Abscess

Definition

Localized collection of pus caused by suppuration:

Buried within:

Tissue
Organ
Confined space

Pathogenesis

Caused by seeding of pyogenic bacteria into tissue

Structure

Central region:

Necrotic leukocytes
Necrotic tissue cells

Surrounding zone:

Preserved neutrophils

Outer region:

Vascular dilation
Parenchymal proliferation
Fibroblastic proliferation
Indicates chronic inflammation and repair

Outcome

Over time:

Abscess may become walled off
Ultimately replaced by connective tissue

Clinical importance

Persistent abscesses or those in critical sites (e.g., brain) may require:

Surgical drainage

4. Ulcers

Definition

A local defect (excavation) of the surface of an organ or tissue
Produced by:

Sloughing (shedding) of inflamed necrotic tissue

Where ulcers occur

Only when:

Tissue necrosis and inflammation exist on or near a surface

Common sites:

Mucosa of:

Mouth
Stomach
Intestines
Genitourinary tract

Skin and subcutaneous tissue of lower extremities:

Especially in older persons with circulatory disturbances
Predisposes to ischemic necrosis

Inflammation pattern

Acute and chronic inflammation often coexist

Examples

Peptic ulcers (stomach, duodenum)
Diabetic leg ulcers

Microscopic progression

Acute stage:

Intense polymorphonuclear infiltration
Vascular dilation at margins

Chronic stage:

Fibroblast proliferation
Scarring
Accumulation of:

Lymphocytes
Macrophages
Plasma cells

At margins and base of ulcer

OUTCOMES OF ACUTE INFLAMMATION

Acute inflammation typically ends in one of three outcomes, influenced by:

Nature and intensity of injury
Tissue and site involved
Host responsiveness

1. Complete Resolution

Definition

Restoration of the inflamed site to normal structure and function

When it occurs

Injury is:

Limited
Short-lived

Minimal tissue destruction
Damaged parenchymal cells can regenerate

Mechanism

Removal of:

Cellular debris
Microbes
By macrophages

Resorption of edema fluid by lymphatics

2. Healing by Connective Tissue Replacement (Scarring / Fibrosis)

When it occurs

After:

Substantial tissue destruction
Injury to tissues incapable of regeneration
Abundant fibrin exudation in tissues or serous cavities (pleura, peritoneum) that cannot be cleared

Mechanism

Connective tissue growth into:

Area of damage
Area of exudate

Converts affected region into:

Fibrous tissue

3. Progression to Chronic Inflammation

When it occurs

Acute inflammation cannot be resolved due to:

Persistence of the injurious agent
Interference with normal healing processes

Exam-safe closing logic

Acute inflammation is not a single pattern, but a framework upon which specific morphologies are layered.
Pattern recognition = etiologic clue, prognosis predictor, and management guide.

CHRONIC INFLAMMATION — LOGIC-BASED NOTE (ZERO OMISSION)

1. Definition & Temporal Nature

Chronic inflammation is an inflammatory response of prolonged duration (weeks to months).
It is characterized by the simultaneous presence of:

Ongoing inflammation
Tissue injury
Attempts at repair

These components coexist in variable proportions.
It may:

Follow acute inflammation, or
Begin insidiously as a low-grade, smoldering process without a preceding acute phase.

2. Causes of Chronic Inflammation (Four Major Settings)

A. Persistent Infections

Caused by microorganisms difficult to eradicate, including:

Mycobacteria
Certain viruses
Fungi
Parasites

These often evoke delayed-type hypersensitivity (cell-mediated immunity).
Outcomes:

Granulomatous inflammation (specific pattern)
OR progression from unresolved acute inflammation → chronic inflammation

Example: acute bacterial pneumonia → chronic lung abscess

B. Hypersensitivity Diseases

Result from excessive or inappropriate immune activation.
Includes:

Autoimmune diseases

Self antigens trigger a self-perpetuating immune response
Causes chronic inflammation + tissue damage
Examples: rheumatoid arthritis, multiple sclerosis

Allergic diseases

Excessive immune responses to harmless environmental antigens
Example: bronchial asthma

Characteristics:

Serve no useful purpose
Often show mixed acute + chronic inflammation
Repeated inflammatory bouts
Fibrosis dominates late stages

C. Prolonged Exposure to Toxic Agents

Exogenous agents

Example: silica particles → silicosis
Nondegradable, inanimate, inhaled over long periods

Endogenous agents

Example: cholesterol and lipids in atherosclerosis

Atherosclerosis is a chronic inflammatory disease of arterial walls.

D. Chronic Inflammation in Non-Classical Inflammatory Diseases

Chronic inflammation contributes to diseases not traditionally considered inflammatory, including:

Neurodegenerative diseases (e.g., Alzheimer disease)
Metabolic syndrome
Type 2 diabetes mellitus
Certain cancers

Inflammation in these settings promotes disease progression.

3. Morphologic Features (Contrast With Acute Inflammation)

Acute inflammation:

Vascular changes
Edema
Neutrophil predominance

Chronic inflammation is characterized by:

Mononuclear cell infiltration

Macrophages
Lymphocytes
Plasma cells

Tissue destruction

Caused by persistent agent or inflammatory cells

Attempts at healing

Connective tissue replacement
Angiogenesis
Fibrosis

Angiogenesis and fibrosis overlap with wound healing and repair.

4. Cells & Mediators of Chronic Inflammation — Overview

Chronic inflammation results from:

Persistent leukocyte infiltration
Ongoing tissue damage
Fibrosis

Driven by local activation of multiple cell types and mediator production.

5. Role of Macrophages (Central Cell)

A. Dominant Cell Type

Macrophages dominate most chronic inflammatory reactions.
Functions:

Phagocytosis
Cytokine and growth factor secretion
Tissue destruction
Activation of lymphocytes (especially T cells)

B. Origin & Distribution

Derived from:

Bone marrow hematopoietic stem cells
Embryonic yolk sac
Fetal liver (early development)

Circulating precursors = monocytes
Tissue locations:

Connective tissues (diffuse)
Liver → Kupffer cells
Spleen & lymph nodes → sinus histiocytes
CNS → microglia
Lung → alveolar macrophages

Collectively called the mononuclear phagocyte system

(formerly reticuloendothelial system)

C. Recruitment & Lifespan

Bone marrow → monocytes → blood → tissues → macrophages
Governed by:

Adhesion molecules
Chemokines (same as neutrophil emigration)

Lifespan:

Blood monocytes: ~1 day
Tissue macrophages: months to years

Macrophages become dominant within 48 hours of inflammation onset.

D. Resident Macrophages

Examples: microglia, Kupffer cells, alveolar macrophages
Derived from yolk sac/fetal liver
Populate tissues early in embryogenesis
Maintained mainly by local proliferation, not monocyte recruitment

E. Macrophage Activation Pathways

1. Classical Activation (M1)

Induced by:

Microbial products (e.g., endotoxin via TLRs)
IFN-γ from T cells

Functions:

Produce NO and ROS
Increase lysosomal enzymes
Kill microbes
Secrete pro-inflammatory cytokines

Role:

Host defense
Inflammatory tissue injury

2. Alternative Activation (M2)

Induced by:

IL-4
IL-13

Produced by:

T lymphocytes
Other cells

Functions:

Not microbicidal
Promote tissue repair
Secrete growth factors
Stimulate angiogenesis
Activate fibroblasts
Promote collagen synthesis

F. Activation Sequence (Conceptual)

Typically:

M1 activation first → destroy offending agent
Followed by M2 activation → initiate repair

However:

This sequence is not consistently documented
Macrophage phenotypes are plastic, not fixed

G. Macrophage-Mediated Tissue Injury

Macrophages secrete:

Cytokines (TNF, IL-1)
Chemokines
Eicosanoids

Functions:

Initiate and propagate inflammation
Present antigens to T cells
Respond to T-cell signals → feedback loop

Excessive activation → major cause of tissue destruction
Fate:

May disappear if irritant removed
Or persist due to:

Continuous recruitment
Local proliferation

6. Role of Lymphocytes

A. General Role

Activated by microbes and environmental antigens
Amplify and sustain chronic inflammation
Especially prominent in:

Autoimmune diseases
Hypersensitivity reactions
Granulomatous inflammation

B. CD4+ T-Cell Subsets & Cytokines

1. TH1 Cells

Secrete IFN-γ
Activate macrophages (classical/M1 pathway)

2. TH2 Cells

Secrete IL-4, IL-5, IL-13
Recruit eosinophils
Promote alternative (M2) macrophage activation

3. TH17 Cells

Secrete IL-17 and related cytokines
Induce chemokines → recruit neutrophils

C. Functional Roles

TH1 + TH17:

Defense against bacteria and viruses
Autoimmune diseases

TH2:

Defense against helminths
Allergic inflammation

D. Macrophage–Lymphocyte Feedback Loop

Macrophages:

Present antigens
Express costimulatory molecules
Secrete IL-12

T cells:

Secrete cytokines
Activate macrophages

Result:

Self-perpetuating cycle
Sustained chronic inflammation

E. B Cells & Plasma Cells

Often present at chronic inflammatory sites
Produce antibodies against:

Persistent foreign antigens
Self antigens
Altered tissue components

Exact role often unclear

F. Tertiary Lymphoid Organs

Organized lymphoid aggregates resembling lymph nodes
Seen in:

Rheumatoid arthritis (synovium)
Hashimoto thyroiditis (thyroid)
Helicobacter pylori gastritis

May perpetuate immune responses
Significance not fully established

7. Other Cells in Chronic Inflammation

A. Eosinophils

Prominent in:

IgE-mediated reactions
Parasitic infections

Recruitment:

Adhesion molecules
Chemokines (e.g., eotaxin)

Granules contain major basic protein

Toxic to parasites
Injures host epithelium

Beneficial + damaging roles

B. Mast Cells

Tissue-resident cells
Derived from bone marrow precursors
Express FcεRI (bind IgE)
Immediate hypersensitivity:

Antigen cross-links IgE
Degranulation → histamine, prostaglandins

Present in chronic inflammation
Secrete many cytokines → promote inflammation

C. Neutrophils in Chronic Inflammation

Although typical of acute inflammation:

May persist for months in chronic disease

Seen in:

Chronic osteomyelitis
Smoking-related lung injury

Driven by:

Persistent microbes
Cytokines from macrophages and T cells

Termed acute on chronic inflammation

8. Granulomatous Inflammation

A. Definition

A form of chronic inflammation
Characterized by:

Aggregates of activated macrophages
Often with T lymphocytes
Sometimes central necrosis

B. Cellular Features

Activated macrophages → epithelioid cells
Fusion → multinucleated giant cells
Purpose:

Attempt to contain hard-to-eradicate agents

Strong T-cell activation contributes to tissue injury

C. Types of Granulomas

1. Immune Granulomas

Caused by persistent T-cell–mediated responses
Triggered by:

Persistent microbes
Self antigens

Cytokines:

IL-2 → T-cell expansion
IFN-γ → macrophage activation

2. Foreign Body Granulomas

Response to inert, non-immunogenic material
Examples:

Talc
Sutures
Fibers

No T-cell–mediated immunity
Epithelioid cells and giant cells surround foreign body
Material visible, often refractile under polarized light

9. Morphology of Granulomas

Microscopy (H&E)

Epithelioid macrophages:

Pink granular cytoplasm
Indistinct borders

Peripheral lymphocyte collar
Older lesions:

Fibroblast rim
Connective tissue

Giant cells:

40–50 µm
Multiple nuclei
Langhans type

Necrosis

Caseating granulomas

Classically tuberculosis
Central cheesy necrosis
Microscopically amorphous eosinophilic debris

Noncaseating granulomas

Crohn disease
Sarcoidosis
Foreign body reactions

Healing

Accompanied by fibrosis
May be extensive

10. Diagnostic Importance

Granulomas have limited differential diagnoses
Tuberculosis must always be excluded
Etiologic identification methods:

Special stains (acid-fast)
Culture
Molecular tests (PCR)
Serology

11. Examples of Granulomatous Diseases (Logic Summary)

Tuberculosis

Caseating granulomas, acid-fast bacilli

Leprosy

Noncaseating granulomas, bacilli in macrophages

Syphilis

Gumma, plasma cells, organisms hard to detect

Cat-scratch disease

Stellate granulomas with neutrophils

Sarcoidosis

Noncaseating granulomas, unknown cause

Crohn disease

Occasional noncaseating granulomas, chronic inflammation

SYSTEMIC EFFECTS OF INFLAMMATION

(Acute-Phase Response)

1. Core Concept

Even localized inflammation produces systemic effects
These are cytokine-mediated reactions called the acute-phase response
Commonly experienced in severe bacterial or viral infections (e.g., pneumonia, influenza)

2. Triggers of the Acute-Phase Response

Microbial products

Bacterial LPS
Viral double-stranded RNA

Other inflammatory stimuli
These stimulate immune cells to release cytokines

3. Key Cytokine Mediators

TNF
IL-1
IL-6
Additional contributors:

Type I interferons

4. Major Components of the Acute-Phase Response

A. Fever (Pyrexia)

Definition

Elevation of body temperature by 1–4°C
Most prominent when inflammation is infection-associated

Pyrogens

Exogenous pyrogens:

Bacterial products (e.g., LPS)

Endogenous pyrogens:

IL-1
TNF

Mechanism (Stepwise Logic)

LPS → leukocyte activation
Leukocytes release IL-1 & TNF
These cytokines:

Increase cyclooxygenase (COX) activity
Convert arachidonic acid → prostaglandins

In the hypothalamus:

PGE₂ stimulates neurotransmitter production
Temperature set point reset upward

Drug Effect

NSAIDs (including aspirin):

Inhibit prostaglandin synthesis
Therefore reduce fever

Biological Role

Exact protective value of fever:

Unclear
Not definitively proven beneficial or harmful

B. Acute-Phase Proteins (APPs)

Definition

Plasma proteins synthesized mainly in the liver
Plasma levels may rise several hundred-fold

Cytokine Control

Hepatocyte synthesis stimulated by:

IL-6
IL-1
TNF

Major Acute-Phase Proteins

C-Reactive Protein (CRP)
Fibrinogen
Serum Amyloid A (SAA)

Functions

CRP & SAA

Bind microbial cell walls
Act as opsonins
Fix complement

Fibrinogen

Binds RBCs → rouleaux formation
Rouleaux sediment faster → ↑ ESR

Clinical Applications

Erythrocyte Sedimentation Rate (ESR)

Simple test indicating inflammation

CRP

Marker of myocardial infarction risk
Linked to inflammation in atherosclerotic plaques
Plaque inflammation → thrombosis → infarction

Pathologic Consequences

Chronic elevation of SAA

Leads to secondary amyloidosis

Hepcidin (another acute-phase peptide)

Regulates iron metabolism
Chronic elevation:

↓ Iron availability
Causes anemia of chronic inflammation

C. Leukocytosis

Definition

Increase in circulating leukocytes
Typical range:

15,000–20,000 cells/mL

Extreme range:

40,000–100,000 cells/mL
Called leukemoid reaction

Mechanisms

Early phase

Cytokines (TNF, IL-1) cause:

Rapid release from bone marrow post-mitotic reserve

Results in:

↑ immature neutrophils
Left shift

Prolonged inflammation

Increased colony-stimulating factors (CSFs)
Bone marrow precursor proliferation
Sustained leukocyte production

Infection-Specific Patterns

Bacterial infections

Neutrophilia

Viral infections

Lymphocytosis
Examples:

Infectious mononucleosis
Mumps
German measles

Allergies & parasitic infestations

Eosinophilia

Certain infections

Typhoid fever
Some viruses
Rickettsiae
Some protozoa
→ Leukopenia

D. Other Systemic Manifestations

Cardiovascular & Thermoregulation

↑ Heart rate
↑ Blood pressure
↓ Sweating

Due to blood flow redistribution:

From skin → deep vascular beds

Purpose:

Minimize heat loss

Neuro-Behavioral Effects

Rigors (shivering)
Chills (seeking warmth)
Anorexia
Somnolence
Malaise

(All mediated by cytokine effects on the brain)

5. Severe Systemic Responses

A. Septic Shock

Cause

Severe bacterial infection → massive cytokine release
Especially:

TNF
IL-1

Pathophysiology

Extremely high cytokine levels cause:

Disseminated intravascular coagulation (DIC)
Hypotensive shock
Metabolic disturbances

Insulin resistance
Hyperglycemia

Clinical Triad

DIC
Hypotension
Metabolic abnormalities

B. Systemic Inflammatory Response Syndrome (SIRS)

Definition

Septic-shock–like syndrome without infection

Causes

Severe burns
Trauma
Pancreatitis
Other major noninfectious insults

6. Transition to Repair

After systemic inflammatory effects:

The body initiates repair

Repair is a healing response
Occurs after:

Inflammation
Other causes of tissue destruction

EXAM LOCK (One-Line Recall)

TNF, IL-1, and IL-6 drive the acute-phase response, producing fever (via PGE₂), acute-phase proteins (CRP, fibrinogen, SAA), leukocytosis, and systemic metabolic, cardiovascular, and neurologic effects, with extreme cytokine excess causing septic shock or SIRS.

OVERVIEW OF TISSUE REPAIR — LOGIC-BASED NOTE (NO OMISSIONS)

1. WHY TISSUE REPAIR IS ESSENTIAL (BIG PICTURE LOGIC)

Survival of an organism depends on the ability to repair damage caused by:

Toxic insults
Inflammation

The inflammatory response has a dual role:

Eliminates microbes and necrotic tissue
Initiates tissue repair

👉 Key logic:

Inflammation is not just destructive → it is the trigger for repair.

2. TWO FUNDAMENTAL PATHWAYS OF TISSUE REPAIR (CORE FRAMEWORK)

Repair of damaged tissues occurs by two reactions:

A. Regeneration

Replacement of damaged tissue with normal tissue
Achieved by:

Proliferation of residual (uninjured) cells
Maturation of tissue stem cells

B. Connective Tissue Deposition (Scar Formation)

Replacement of damaged tissue with fibrous connective tissue
Occurs when complete restitution is not possible

👉 Most injuries heal by a COMBINATION of both.

3. REGENERATION — MECHANISM & LIMITS

Definition

Regeneration = replacement of damaged components with return toward a normal state

How regeneration occurs

Proliferation of cells that survive injury
These cells must:

Retain the capacity to proliferate

In some tissues, tissue stem cells contribute

Tissues with strong regenerative ability

Rapidly dividing epithelia:

Skin
Intestines

Some parenchymal organs:

Especially the liver

Species differences (important exam contrast)

Lower animals (salamanders, fish):

Can regenerate entire limbs or appendages

Mammals:

Limited regenerative capacity
Only some tissue components fully restore themselves

4. CONNECTIVE TISSUE DEPOSITION (SCAR FORMATION)

When scar formation occurs

When injured tissues:

Cannot undergo complete restitution
Or when supporting structures (ECM) are severely damaged

Characteristics

Deposition of connective (fibrous) tissue
Results in a scar
Scar:

Is not normal tissue
But provides enough structural stability
Allows the tissue to function

Fibrosis (definition and sites)

Fibrosis = extensive collagen deposition
Occurs in:

Lungs
Liver
Kidney
Other organs in chronic inflammation
Myocardium after extensive ischemic necrosis (infarction)

Organization (high-yield term)

If fibrosis develops in a space previously occupied by an inflammatory exudate:

It is called organization

Example:

Organizing pneumonia (lung)

5. SHARED FEATURES OF REGENERATION & SCARRING

Both processes involve:

Cell proliferation
Close interactions between cells and the extracellular matrix (ECM)

6. CELL AND TISSUE REGENERATION — CORE DRIVERS

Regeneration depends on:

Cell proliferation
Growth factor signaling
Integrity of the extracellular matrix
Differentiation of stem cells into mature cells

7. CELL PROLIFERATION DURING TISSUE REPAIR

Cell types that proliferate

Residual tissue cells

Attempt to restore normal structure

Endothelial cells

Form new blood vessels (angiogenesis)

Fibroblasts

Produce collagen and fibrous tissue for scars

8. INTRINSIC PROLIFERATIVE CAPACITY OF TISSUES

Tissues are classified into three groups:

A. LABILE TISSUES

Cells are constantly lost and replaced
Derived from:

Tissue stem cells
Rapidly proliferating progenitors

Examples:

Hematopoietic cells (bone marrow)
Surface epithelia:

Skin (basal squamous layer)
Oral cavity
Vagina
Cervix
GI tract epithelium
Uterus
Fallopian tubes
Transitional epithelium (urinary tract)
Ductal epithelium of exocrine glands (salivary, pancreas, biliary)

👉 These tissues regenerate readily, provided stem cells are preserved.

B. STABLE TISSUES

Normally in G0 phase
Can re-enter cell cycle after injury
Examples:

Parenchyma of:

Liver
Kidney
Pancreas

Endothelial cells
Fibroblasts
Smooth muscle cells

👉 Important in wound healing.

C. PERMANENT TISSUES

Terminally differentiated
Non-proliferative
Injury is irreversible
Results in scar formation
Examples:

Neurons
Cardiac muscle cells

⚠️ Exception:

Skeletal muscle

Has limited regenerative capacity via satellite cells
Satellite cells lie beneath the endomysial sheath

9. SIGNALS DRIVING CELL PROLIFERATION

Growth factors

Produced near the site of injury
Main source:

Activated macrophages

Additional sources:

Epithelial cells
Stromal cells

Growth factor characteristics

Some act on multiple cell types
Others are cell-specific
Many bind to ECM proteins

Concentrated at injury site

Mechanism of action

Activate intracellular signaling pathways
Induce:

Gene expression
Cell cycle progression
Biosynthesis of organelles and molecules needed for division

10. ROLE OF ECM AND INTEGRINS

Cells bind ECM proteins using integrins
Integrin signaling:

Stimulates cell proliferation
Cooperates with growth factor signaling

11. STEM CELLS IN REGENERATION

Regeneration is supplemented by:

Differentiation of stem cells → mature cells

Most important in adults:

Tissue stem cells

These stem cells:

Reside in specialized niches
Injury triggers signals that:

Activate quiescent stem cells
Induce proliferation and differentiation

12. MECHANISMS OF TISSUE REGENERATION — ORGAN-SPECIFIC

A. EPITHELIAL REGENERATION

Seen in:

Skin
Intestinal tract

Conditions:

Basement membrane must be intact

Mechanism:

Proliferation of residual epithelial cells
Differentiation from stem cells
Migration of new cells to fill defect

Result:

Restoration of tissue integrity

B. PARENCHYMAL ORGAN REGENERATION

Generally limited
Organs with some regenerative capacity:

Pancreas
Adrenal
Thyroid
Lung

Kidney example:

Removal of one kidney →

Remaining kidney undergoes:

Hypertrophy
Hyperplasia of proximal tubular cells

Mechanism likely involves:

Local growth factors
ECM interactions

LIVER REGENERATION

Example illustrating framework collapse → scar:

Extensive destruction of liver with collapse of reticulin framework (as in a liver abscess)
Leads to scar formation even though remaining liver cells can regenerate

If entire tissue is damaged by infection/inflammation:

Regeneration is incomplete
Scarring occurs along with regeneration

Restoration of normal tissue architecture requires residual tissue to be structurally intact.

Example: partial surgical resection of liver

11) When can normal architecture be restored?

Liver regeneration capacity is extraordinary and provides a model system.
After surgical removal of a kidney:

Remaining kidney shows compensatory response with:

Hypertrophy
Hyperplasia of proximal duct cells

Mechanisms are not understood, but likely involve:

Local growth factor production
Interactions of cells with ECM

Organs with some regenerative capacity include:

Pancreas
Adrenal
Thyroid
Lung

Except for the liver, regeneration is usually limited.
Regeneration can occur in parenchymal organs with proliferative capacity.

10) Regeneration in parenchymal organs

Newly generated cells:

Migrate to fill the defect
Restore tissue integrity

Growth factor source in these epithelia:

Residual epithelial cells produce growth factors involved in the process

Condition for full epithelial regeneration:

The basement membrane must be intact

Injured cells are rapidly replaced by:

Proliferation of residual cells
Differentiation of cells derived from tissue stem cells

9) Regeneration in intestinal epithelium and skin

Importance of regeneration varies by:

Tissue type
Severity of injury

8) How regeneration varies

MECHANISMS OF TISSUE REGENERATION

Injury is believed to trigger signals in niches that:

Activate quiescent stem cells
Induce proliferation
Induce differentiation into mature cells that repopulate injured tissue

Tissue stem cells live in specialized niches.
In adults, the most important stem cells for regeneration after injury are tissue stem cells.
Proliferation of residual cells is supplemented by development of mature cells from stem cells.

7) Stem cells in regeneration

Integrin signals can also stimulate cell proliferation (in addition to growth factors)
Cells bind ECM proteins via integrins

Integrins and ECM signaling

Support biosynthesis of molecules and organelles needed for cell division
Drive cells through the cell cycle
Induce changes in gene expression
Activate signaling pathways

What growth factors do inside cells

They are displayed at the injury site at high concentrations.
Several growth factors bind to ECM proteins.

Growth factors and ECM localization

Additional sources:

Epithelial cells
Stromal cells

Most important sources:

Macrophages activated by tissue injury

Growth factors are produced by cells near the site of damage.
Many growth factors exist:

Some act on multiple cell types
Some are cell-type specific

Growth factor properties and sources

Signals from the extracellular matrix (ECM)
Signals from growth factors

Cell proliferation is driven by:

6) What drives cell proliferation in repair?

Skeletal muscle is usually considered nondividing, but:

Satellite cells attached to the endomysial sheath provide some regenerative capacity.

Injury is irreversible and results in a scar because cells cannot regenerate.
Examples:

Majority of neurons
Cardiac muscle cells

Terminally differentiated, nonproliferative cells.

C) Permanent Tissues

This growth-factor–driven proliferation is particularly important in wound healing.
Examples:

Parenchyma of most solid organs:

Liver
Kidney
Pancreas

Also normally quiescent but can proliferate in response to growth factors:

Endothelial cells
Fibroblasts
Smooth muscle cells

They can divide in response to injury or loss of tissue mass.
Cells are normally in G0 and not proliferating.

B) Stable Tissues

These tissues regenerate readily after injury as long as the stem cell pool is preserved.
Examples include:

Hematopoietic cells in bone marrow
Many surface epithelia, including:

Basal layers of squamous epithelia:

Skin
Oral cavity
Vagina
Cervix

Cuboidal epithelia of ducts draining exocrine organs:

Salivary glands
Pancreas
Biliary tract

Columnar epithelium of:

Gastrointestinal tract
Uterus
Fallopian tubes

Transitional epithelium of:

Urinary tract

Replacement comes from:

Tissue stem cells
Rapidly proliferating immature progenitors

Cells are constantly lost and must be continually replaced.

A) Labile Tissues

Repair capacity depends partly on intrinsic proliferative potential, grouped into three categories:

5) Tissue Proliferative Capacity Determines Repair Ability

Fibroblasts (source of fibrous tissue forming scar to fill defects not corrected by regeneration)
Vascular endothelial cells (create new vessels to supply nutrients needed for repair)
Remnants of injured tissue (attempt to restore normal structure)

4) Which cells proliferate during tissue repair?

CELL PROLIFERATION: SIGNALS AND CONTROL MECHANISMS

Before examples, control of cell proliferation is considered (general principles summarized elsewhere).
It also involves development of mature cells from stem cells.
It is critically dependent on integrity of the ECM.
Regeneration involves cell proliferation driven by growth factors.

3) Core Drivers of Regeneration

CELL AND TISSUE REGENERATION

Examples:

Cutaneous wound healing
Fibrosis (scarring) in parenchymal organs

Features of regeneration and healing by scar formation
General mechanisms of cellular proliferation and regeneration

What is discussed next in the sequence

Both processes involve:

Proliferation of various cells
Close interactions between cells and the extracellular matrix (ECM)

After many common injuries, both regeneration and scar formation contribute in varying degrees.

Combined Outcome After Injury

If fibrosis develops in a tissue space occupied by an inflammatory exudate, it is called organization.

Example: organizing pneumonia affecting the lung.

Fibrosis refers to extensive deposition of collagen in:

Lungs
Liver
Kidney
Other organs as a consequence of chronic inflammation
Also in myocardium after extensive ischemic necrosis (infarction)

A fibrous scar is not normal tissue, but it provides enough structural stability for the injured tissue to usually function.
If injured tissues cannot fully return to normal, or if the supporting structures are severely damaged, repair occurs via deposition of connective (fibrous) tissue, producing a scar.

B) Connective Tissue Deposition (Scar Formation)

Regenerative ability differs across species:

Lower animals (e.g., salamanders, fish) can regenerate entire limbs/appendages.
Mammals have limited regenerative capacity, and only some components of most tissues can fully restore themselves.

In other situations, tissue stem cells contribute to restoration of damaged tissues.
Examples of tissues with strong regenerative proliferation:

Rapidly dividing epithelia of skin and intestines.
Some parenchymal organs, especially the liver.

Regeneration occurs by proliferation of cells that survive the injury and retain capacity to proliferate.
Regeneration is the replacement of damaged components with restoration toward a normal state.

A) Regeneration

2) Two Main Repair Pathways

Repair occurs by two types of reactions:

Regeneration by proliferation of residual (uninjured) cells and maturation of tissue stem cells.
Connective tissue deposition to form a scar.

The inflammatory response not only eliminates microbes and damaged tissue but also initiates the repair process.
Tissue repair is critical for survival because it restores damage caused by toxic insults and inflammation.

🧠 EXAM REFLEX BLOCK — Core Drivers of Regeneration & Repair

🔁 Two Repair Pathways (ALWAYS think first)

Regeneration → replacement of damaged tissue with normal tissue
Scar formation (fibrosis) → replacement with connective tissue (collagen)

👉 Most injuries heal by a MIX of both, not purely one.

🧬 What Drives Both Processes

Cell proliferation
Cell–ECM interactions
Initiated by inflammation (clears debris + triggers repair)

🔬 Regeneration — Exam Locks

Occurs when:

ECM framework is intact
Injured cells can proliferate

Mechanism:

Proliferation of residual surviving cells
Contribution from tissue stem cells

High regenerative capacity:

Skin epithelium
Intestinal epithelium
Liver (parenchymal organ with strong regenerative ability)

Definition trigger:

“Return toward a normal state” = regeneration

🧱 Scar Formation / Fibrosis — Exam Locks

Occurs when:

Severe or chronic injury
ECM + supporting structures destroyed
Tissue cannot fully regenerate

Hallmark:

Collagen deposition

Common organs affected:

Lung
Liver
Kidney
Heart (post-myocardial infarction)

Functional concept:

Scar ≠ normal tissue
But provides structural stability → allows basic function

🫁 Organization — High-Yield Term

Definition: Fibrosis developing in a space previously occupied by inflammatory exudate
Classic example:

Organizing pneumonia (lung)

Buzzword link:

Exudate → fibroblasts → collagen = organization

🌍 Species Difference — Easy MCQ

Lower animals (salamanders, fish) → regenerate whole limbs
Mammals → limited regeneration, rely more on scarring

🔄 Inflammation–Repair Link

Inflammation:

Removes dead cells & microbes
Activates growth factors, cytokines, ECM signals

Without inflammation → repair does not start properly

🧠 One-Line Exam Reflex

If ECM is intact → regeneration; if ECM is destroyed or injury is chronic → fibrosis (scar).

⚠️ Exam Traps to Avoid

Scar = functional replacement, not true restoration
Fibrosis can occur inside organs, not just skin
Most healing = regeneration + scar together, not either/or

Repair by Scarring (Connective Tissue Repair)

Core Concept

Repair by scarring occurs when regeneration alone is insufficient.
Injured cells are replaced by connective tissue, forming a scar, or by a combination of regeneration + scarring.
Unlike regeneration (true restoration), scarring patches tissue but does not restore original structure or function.
Scarring occurs when:

Injury is severe or chronic
Parenchymal cells + epithelia + connective tissue framework are damaged
Non-dividing (permanent) cells are injured (e.g., myocardium)

Although commonly used for skin wounds, “scar” also refers to collagen replacement of parenchyma in any organ, e.g. heart after myocardial infarction.

Sequential Steps in Scar Formation

Scar formation follows ordered, overlapping stages after tissue injury.

1. Hemostasis (Immediate – Minutes)

Platelet hemostatic plug forms within minutes.
Functions:

Stops bleeding
Provides a temporary scaffold for inflammatory cells

Platelets also release chemokines and growth mediators that initiate later phases.

2. Inflammation (Hours → Days)

Cellular Recruitment (6–48 hours)

Chemotactic signals include:

Complement breakdown products
Chemokines from activated platelets
Other locally produced mediators

Neutrophils arrive first, followed by monocytes → macrophages

Role of Macrophages (Central Regulators)

M1 macrophages

Clear microbes and necrotic tissue
Promote inflammation (positive feedback)

M2 macrophages

Produce growth factors
Stimulate cell proliferation and repair

As debris and injurious agents are cleared:

Inflammation resolves
Exact mechanisms of resolution remain not fully defined

3. Cell Proliferation (Up to ~10 Days)

Multiple cell populations expand and migrate to close the clean wound.

a. Epithelial Cells

Respond to locally produced growth factors
Migrate over wound surface
Restore epithelial continuity

b. Endothelial & Vascular Cells

Proliferate to form new blood vessels
Process = angiogenesis
Essential for nutrient and oxygen delivery

c. Fibroblasts

Migrate into wound
Proliferate
Begin collagen deposition

Granulation Tissue (Hallmark of Healing)

Formed by:

Proliferating fibroblasts
Loose connective tissue
Numerous new blood vessels
Scattered chronic inflammatory cells (mainly macrophages)

Appearance:

Pink, soft, granular
Seen beneath scabs in skin wounds

Function:

Temporary repair tissue that fills the defect

4. Remodeling (Weeks → Months/Years)

Begins 2–3 weeks after injury
Converts granulation tissue into a stable fibrous scar
Includes:

Collagen reorganization
Vascular regression
Increased tensile strength

Healing Patterns in Skin (Conceptual Continuum)

Primary intention (first intention)

Well-apposed wounds (e.g. surgical incisions)
Minimal scarring

Secondary intention

Large wounds
Combination of regeneration + scarring

These represent degrees of the same processes, not separate mechanisms.

✅ EXAM REFLEX BLOCK — REPAIR BY SCARRING (CONNECTIVE TISSUE REPAIR)

Core Definition (Reflex line)

Repair by scarring = replacement of injured tissue by connective tissue (collagen) when regeneration is inadequate, resulting in structural patching without full functional restoration.

When scarring occurs (Trigger lock 🔒)

Injury is severe or chronic
Parenchymal cells + epithelium + connective tissue framework are destroyed
Damage involves permanent (non-dividing) cells (e.g. myocardium)
Occurs in any organ, not only skin

→ e.g. fibrous scar after myocardial infarction

Big Picture Logic (One-glance recall)

Regeneration → restores normal tissue
Scarring → fills defect with collagen
Most real wounds → regeneration + scarring together

Sequential Stages of Scar Formation (Order lock 🔒)

1️⃣ Hemostasis (Minutes)

Platelet plug forms immediately
Functions:

Stops bleeding
Provides temporary scaffold

Platelets release:

Chemokines
Growth factors → trigger inflammation & repair

2️⃣ Inflammation (Hours → Days)

Cell recruitment (6–48 h)

Chemotactic signals:

Complement products
Platelet-derived mediators
Local cytokines

Neutrophils first → monocytes → macrophages

Macrophages = master regulators (Exam favorite ⭐)

M1 macrophages

Phagocytose debris & microbes
Promote inflammation

M2 macrophages

Secrete growth factors
Stimulate angiogenesis, fibroblast proliferation, collagen synthesis

As debris clears:

Inflammation resolves
Exact resolution mechanisms = not fully defined

3️⃣ Cell Proliferation (Up to ~10 days)

Multiple cell lines expand to close the clean wound.

a. Epithelial cells

Stimulated by local growth factors
Migrate across wound surface
Restore epithelial continuity

b. Endothelial cells

Form new vessels via angiogenesis
Supply oxygen & nutrients

c. Fibroblasts

Migrate into wound
Proliferate
Begin collagen deposition

Granulation Tissue (Hallmark 🔑)

Composition:

Proliferating fibroblasts
Loose connective tissue
Numerous new capillaries
Scattered macrophages

Appearance:

Pink, soft, granular

Function:

Temporary repair tissue filling the defect

4️⃣ Remodeling (Weeks → Months/Years)

Starts 2–3 weeks after injury
Granulation tissue → mature fibrous scar
Key processes:

Collagen reorganization
Regression of excess vessels
↑ Tensile strength

Healing Patterns in Skin (Concept lock 🧠)

Primary intention

Clean, well-apposed wounds (e.g. surgical incision)
Minimal granulation tissue
Minimal scarring

Secondary intention

Large tissue defects
Prominent granulation tissue
More collagen deposition and scarring
Combination of regeneration + scarring

Ultimate One-Line Exam Reflex

Repair by scarring is an ordered process of hemostasis, inflammation, proliferation with granulation tissue formation, and remodeling, resulting in collagen-based tissue replacement rather than true regeneration.

Angiogenesis

Definition & Importance

Formation of new blood vessels from existing ones
Required for:

Wound healing
Collateral circulation in ischemia
Tumor growth beyond original blood supply

Therapeutic relevance:

Augmentation → ischemic disease
Inhibition → cancer, wet macular degeneration

Steps of Angiogenesis

Vasodilation (NO-mediated)
Increased permeability (VEGF-mediated)
Pericyte detachment + basement membrane breakdown
Endothelial migration toward injury
Endothelial proliferation behind the migrating “tip”
Capillary tube formation
Recruitment of periendothelial cells

Pericytes (capillaries)
Smooth muscle cells (larger vessels)

Suppression of endothelial proliferation
Basement membrane deposition

Endothelial Progenitor Cells

Present in bone marrow
Can contribute to angiogenesis
Likely play minor role in routine wound healing

Molecular Regulation of Angiogenesis

Growth Factors

VEGF-A

Endothelial migration & proliferation
Vasodilation via NO
Vascular lumen formation

FGF-2

Endothelial proliferation
Macrophage & fibroblast migration
Epithelial cell migration

PDGF

Recruits smooth muscle cells

TGF-β

Suppresses endothelial proliferation
Enhances ECM production

Notch Signaling

Interacts with VEGF
Controls vessel sprouting and spacing
Ensures effective tissue perfusion

ECM & Enzymes

ECM proteins interact with endothelial integrins
Provide scaffold for vessel growth
Matrix metalloproteinases (MMPs)

Degrade ECM
Allow tube extension and remodeling

Vessel Leakiness

Newly formed vessels are leaky due to:

Incomplete junctions
VEGF-induced permeability

Explains persistent edema after inflammation resolves

✅ EXAM REFLEX BLOCK — ANGIOGENESIS

Core Definition (Reflex line)

Angiogenesis = formation of new blood vessels from pre-existing vessels

Why it matters (One-glance recall)

Essential for:

Wound healing
Collateral circulation in ischemia
Tumor growth beyond diffusion limits

Therapeutic targeting:

↑ Angiogenesis → for ischemic disease
↓ Angiogenesis → for cancer, wet macular degeneration

Sequential Steps (Order lock 🔒)

Vasodilation — NO-mediated
↑ Vascular permeability — VEGF
Pericyte detachment + basement membrane breakdown
Endothelial migration toward injury (tip cells)
Endothelial proliferation behind the tip
Capillary tube formation
Recruitment of peri-endothelial cells

Pericytes → capillaries
Smooth muscle cells → larger vessels

Suppression of endothelial proliferation
Basement membrane deposition & vessel stabilization

👉 Exam pearl: Early growth = migration & proliferation; late phase = stabilization and maturation

Endothelial Progenitor Cells (MCQ trap)

Present in bone marrow
Can contribute to angiogenesis
Minor role in routine wound healing

Molecular Regulators (High-yield mapping)

VEGF-A

↑ Endothelial migration & proliferation
NO-mediated vasodilation
Promotes vascular lumen formation
↑ Vascular permeability

FGF-2

↑ Endothelial proliferation
↑ Macrophage & fibroblast migration
↑ Epithelial cell migration

PDGF

Recruits smooth muscle cells
Stabilizes newly formed vessels

TGF-β

Suppresses endothelial proliferation
↑ ECM production
Switches angiogenesis from growth → maturation

Notch Signaling (Pattern lock 🧠)

Interacts with VEGF
Controls sprouting vs spacing
Ensures functional perfusion, not chaotic vessel growth

ECM & Enzymes

ECM proteins + endothelial integrins → scaffold for growth
Matrix metalloproteinases (MMPs):

Degrade ECM
Allow tube extension & remodeling

Why new vessels are leaky (Classic exam question)

Incomplete endothelial junctions
VEGF-induced permeability
Explains persistent edema after inflammation resolves

One-line exam reflex

Angiogenesis is VEGF-driven endothelial migration and proliferation followed by PDGF- and TGF-β-mediated vessel stabilization, with early leakiness due to immature junctions.

Activation of Fibroblasts & ECM Deposition

Two Major Steps

Fibroblast migration and proliferation
ECM protein deposition

Key Cytokines & Growth Factors

PDGF
FGF-2
TGF-β (most important)

Cellular Sources

Inflammatory cells
Especially M2 macrophages

Fibroblast Behavior

Enter wound from edges
Migrate toward center
Some differentiate into myofibroblasts

Contain smooth muscle actin
Contract wound margins

Increase synthesis of:

Collagen
Other ECM proteins

TGF-β: Master Regulator of Fibrosis

Functions

Stimulates fibroblast migration & proliferation
Increases collagen & fibronectin synthesis
Inhibits ECM degradation (↓ metalloproteinases)
Promotes fibrosis in:

Lung
Liver
Kidney (chronic inflammation)

Anti-inflammatory:

Inhibits lymphocyte proliferation
Suppresses leukocyte activity

Regulation

Controlled mainly by:

Activation of latent TGF-β
Secretion rate
ECM interactions (integrins)

Fibrillin microfibrils regulate TGF-β bioavailability

Collagen Deposition & Scar Maturation

Collagen synthesis:

Begins day 3–5
Continues for weeks

Net accumulation depends on:

↑ synthesis
↓ degradation

Granulation tissue becomes:

Less vascular
Pale, avascular mature scar

✅ EXAM REFLEX BLOCK — Activation of Fibroblasts & ECM Deposition

Two-step repair = Fibroblast migration/proliferation → ECM deposition
Key drivers: TGF-β (most important) > PDGF > FGF-2
Main source: M2 macrophages (wound-healing phenotype)

Fibroblast Actions (Reflex lines)

Fibroblasts enter from wound edges → move to center
Differentiate into myofibroblasts→ contain smooth muscle actin→ contract wound margins
↑ synthesis of collagen + ECM proteins

TGF-β — Master Regulator (High-yield)

↑ fibroblast migration & proliferation
↑ collagen + fibronectin synthesis
↓ ECM degradation (↓ metalloproteinases)
Pro-fibrotic in lung, liver, kidney (chronic inflammation)
Anti-inflammatory: inhibits lymphocytes & leukocytes
Regulation: activation of latent TGF-β, secretion rate, ECM–integrin interactions
Fibrillin microfibrils control TGF-β bioavailability

Collagen & Scar Maturation (Timing lock)

Collagen synthesis starts day 3–5
Continues for weeks
Net collagen = ↑ synthesis + ↓ degradation
Granulation tissue → less vascular → pale, avascular mature scar

One-line exam pearl

TGF-β from M2 macrophages drives fibroblast migration, myofibroblast contraction, collagen deposition, and scar maturation while suppressing inflammation.

Remodeling of Connective Tissue

Scar Strengthening

Increased tensile strength via:

Collagen cross-linking
Larger collagen fibers

Collagen type shift:

Type III → Type I

Skin wounds regain 70–80% strength by 3 months

Wound Contraction

Early: myofibroblasts
Late: collagen cross-linking

ECM Degradation

Matrix Metalloproteinases (MMPs)

Zinc-dependent enzymes
Produced by:

Fibroblasts
Macrophages
Neutrophils
Synovial cells
Some epithelial cells

Types

Interstitial collagenases (MMP-1, -2, -3)

Cleave fibrillar collagen

Gelatinases (MMP-2, -9)

Degrade amorphous collagen & fibronectin

Stromelysins (MMP-3, -10, -11)

Degrade proteoglycans, laminin, fibronectin, amorphous collagen

Other Enzymes (Less Important)

Neutrophil elastase
Cathepsin G
Plasmin
Serine proteinases

Regulation

TIMPs (tissue inhibitors of metalloproteinases)

Produced by mesenchymal cells

Balance of MMPs and TIMPs determines scar size and quality

Morphology

Granulation Tissue

Proliferating fibroblasts
Thin-walled, delicate capillaries
Loose ECM
Macrophage-rich inflammation
Amount depends on:

Size of tissue defect
Intensity of inflammation

Scar / Fibrosis

Inactive spindle-shaped fibroblasts
Dense collagen
Elastic tissue fragments
Other ECM components

Special Stains

Trichrome stain

Collagen = blue
Muscle = red
RBCs = orange

Elastin stain

Elastic fibers

Reticulin stain

Type III collagen
Prominent in early scars

🔒 EXAM REFLEX BLOCK — Remodeling of Connective Tissue (High-Yield Locks)

🧠 Scar Strength

Final scar strength depends on collagen remodeling, not cell number.
Type III collagen → Type I collagen = hallmark of maturation.
Cross-linking + thicker fibers = ↑ tensile strength.
Never returns to 100% → max 70–80% by ~3 months (classic MCQ).

👉 Exam trap: If asked “why scars are weak” → imperfect collagen re-architecture, not poor epithelialization.

✋ Wound Contraction

Early contraction → driven by myofibroblasts (actin–myosin).
Late contraction → due to collagen cross-linking and reorganization.
Important in secondary intention wounds.

👉 Exam reflex:

Early = cells, Late = collagen.

🧬 ECM Degradation — MMP System

Matrix metalloproteinases (MMPs) are:

Zinc-dependent
Key regulators of scar size

Produced by:

Fibroblasts
Macrophages
Neutrophils
Synovial cells
Some epithelial cells

👉 One-liner: Scar remodeling = collagen synthesis − collagen degradation.

🧪 MMP Types — Must Match Enzyme → Substrate

Interstitial collagenases (MMP-1, -2, -3)

→ cleave Fibrillar collagen

Gelatinases (MMP-2, -9)

→ Denature collagen + fibronectin

Stromelysins (MMP-3, -10, -11)

→ degrade Proteoglycans, laminin, fibronectin

👉 Exam trap: Don’t mix gelatinases with intact fibrillar collagen.

⚖️ Regulation — TIMPs

TIMPs produced by mesenchymal cells.
Final scar outcome depends on:

MMP : TIMP balance

↑ MMPs → excessive degradation
↑ TIMPs → fibrosis / excessive scar

👉 Key phrase: Scar size = balance, not absolute collagen.

🌱 Granulation Tissue — Recognition Pattern

Pink, soft, granular appearance
Components:

Proliferating fibroblasts
Thin-walled capillaries
Loose ECM
Macrophage-rich inflammation

Amount ∝:

Defect size
Inflammation intensity

👉 Exam reflex: Granulation tissue = healing in progress, not scar.

🧱 Scar / Fibrosis — Final Morphology

Inactive spindle-shaped fibroblasts
Dense collagen bundles
Fragmented elastic fibers
Reduced cellularity & vascularity

👉 Exam contrast:

Granulation tissue → cellular + vascular
Scar → collagen-dense + hypocellular

🎨 Special Stains — Guaranteed Viva Points

Trichrome stain

Collagen → Blue
Muscle → Red
RBCs → Orange

Elastin stain

Elastic fibers

Reticulin stain

Type III collagen
Prominent in early scars

👉 Exam reflex: Early scar → reticulin positive.

🧠 One-Line Exam Summary

Remodeling strengthens scars by replacing type III with type I collagen, increasing cross-linking, and balancing MMP-mediated degradation via TIMPs — restoring only 70–80% tensile strength.

Factors That Impair Tissue Repair

Tissue repair can be impaired by factors that reduce the quality or adequacy of the reparative process.
Interfering factors can be:

Extrinsic (e.g., infection) or intrinsic to the injured tissue.
Systemic or local.

Infection

Infection is one of the most important causes of delayed healing.
It delays healing because it:

Prolongs inflammation.
Potentially increases local tissue injury.

Diabetes

Diabetes is a metabolic disease that compromises tissue repair for many reasons.
It is an important systemic cause of abnormal wound healing.

Nutritional status

Nutritional status has profound effects on repair.
Examples of nutritional problems that impair repair:

Protein malnutrition → inhibits collagen synthesis → retards healing.
Vitamin C deficiency → inhibits collagen synthesis → retards healing.

Glucocorticoids (steroids)

Glucocorticoids have well-documented anti-inflammatory effects.
Their administration may produce weak scars because they:

Inhibit TGF-β production.
Diminish fibrosis.

Sometimes the anti-inflammatory effect is desirable.

Example:

In corneal infections, glucocorticoids may be prescribed with antibiotics to reduce opacity caused by collagen deposition.

Mechanical factors

Mechanical factors (e.g., increased local pressure or torsion) can cause wounds to pull apart.
This pulling apart is called dehiscence.

Poor perfusion

Poor perfusion impairs healing.
Causes include:

Arteriosclerosis and diabetes (arterial supply problem).
Obstructed venous drainage (venous outflow problem), e.g., varicose veins.

Foreign bodies

Foreign bodies impede healing.
Examples:

Fragments of steel.
Glass.
Even bone.

Type and extent of tissue injury

The type and extent of injury determine the repair outcome.
Complete restoration can occur only in tissues composed of cells that can proliferate.
Even in proliferative tissues:

Extensive injury usually leads to incomplete regeneration and at least partial loss of function.

Injury to tissues with nondividing cells must inevitably result in scarring.

Example:

Healing of a myocardial infarct results in scarring.

Location of injury and tissue character

The location and the type of tissue/space where injury occurs matters.
Example: inflammation in tissue spaces (pleural, peritoneal, synovial cavities)

If small exudates:

They may be resorbed and digested by leukocyte proteolytic enzymes.
This leads to resolution and restoration of normal tissue architecture.

If the exudate is too large to be fully resorbed:

It undergoes organization.
During organization:

Granulation tissue grows into the exudate.
Ultimately a fibrous scar forms.

Clinical Examples of Abnormal Wound Healing and Scarring

Complications in repair can arise from abnormalities in any basic component of the process, including:

Deficient scar formation.
Excessive formation of repair components.
Formation of contractures.

Defects in Healing: Chronic Wounds

Chronic wounds occur due to combinations of local and systemic factors.
Common examples:

Venous leg ulcers

Develop most often in elderly people.
Cause: chronic venous hypertension.

Due to severe varicose veins or congestive heart failure.

Features:

Deposits of iron pigment (hemosiderin) are common due to red cell breakdown.
There may be accompanying chronic inflammation.

Why they fail to heal:

Poor delivery of oxygen to the ulcer site.

Arterial ulcers

Develop in individuals with atherosclerosis of peripheral arteries.
Especially associated with diabetes.
Mechanism:

Ischemia → atrophy → then necrosis of skin and underlying tissues.

Clinical feature:

Lesions can be quite painful.

Pressure sores

Areas of skin ulceration and necrosis of underlying tissues.
Cause:

Prolonged compression of tissue against bone.

Typical setting:

Bedridden, immobile elderly individuals with multiple morbidities.

Mechanism:

Mechanical pressure + local ischemia.

Diabetic ulcers

Affect lower extremities, especially the feet.
Tissue necrosis and failure to heal result from:

Small vessel disease causing ischemia.
Neuropathy.
Systemic metabolic abnormalities.
Secondary infections.

Histology:

Epithelial ulceration.
Extensive granulation tissue in underlying dermis.

Dehiscence as a consequence of failed healing

In some cases, failure of healing leads to dehiscence (wound rupture).
Not common, but occurs most frequently after abdominal surgery.
Trigger:

Increased abdominal pressure (vomiting, coughing, ileus).

Excessive Scarring

Excessive formation of repair components can cause:

Hypertrophic scars.
Keloids.

Hypertrophic scar

Due to accumulation of excessive collagen → raised scar.
Behavior:

Often grow rapidly.
Contain abundant myofibroblasts.
Tend to regress over several months.

Typical cause:

After thermal or traumatic injury involving deep dermis.

Keloid

If scar tissue:

Grows beyond the boundaries of the original wound
And does not regress
It is a keloid.

Predisposition:

Some individuals are predisposed, particularly those of African descent.

Exuberant granulation

Deviation characterized by:

Formation of excessive granulation tissue.
Tissue protrudes above surrounding skin level.
It blocks re-epithelialization.

Also called “proud flesh”.
Management:

Must be removed by cautery or surgical excision to allow restoration of epithelial continuity.

Desmoids (aggressive fibromatoses)

Rarely, incisional scars or traumatic injuries may be followed by exuberant proliferation of:

Fibroblasts.
Other connective tissue elements.

Behavior:

May recur after excision.

Name:

Desmoids / aggressive fibromatoses.

Tumor biology framing:

Lies in the “gray zone” between benign and malignant low-grade tumors.

Contractures

Wound contraction is a normal part of healing.
Exaggeration of wound contraction causes:

Contracture.
Deformities of the wound and surrounding tissues.

Common sites:

Palms.
Soles.
Anterior thorax.

Typical setting:

After serious burns.

Functional consequence:

Can compromise joint movement.

Fibrosis in Parenchymal Organs

Fibrosis = excessive deposition of collagen and other ECM components in a tissue.
“Scar” and “fibrosis” can overlap, but:

Fibrosis most often refers to abnormal collagen deposition in internal organs in chronic disease.

Mechanisms:

Same basic mechanisms as skin scar formation during tissue repair.

Nature of fibrosis:

A pathologic process induced by persistent injurious stimuli:

Chronic infections.
Immunologic reactions.

Typically associated with loss of tissue.

Clinical importance:

Causes substantial organ dysfunction and may lead to organ failure.

Central cytokine: TGF-β

Major cytokine involved in fibrosis is TGF-β.
Why TGF-β activity becomes increased is not precisely known, but key triggers include:

Cell death by necrosis or apoptosis.
Production of ROS.

These triggers are important regardless of tissue.

Collagen-producing cells vary by organ

Cells producing collagen in response to TGF-β vary by tissue.
In most organs (e.g., lung and kidney):

Myofibroblasts are the main collagen source.

In liver cirrhosis:

Stellate cells are the major collagen producers.

Examples of fibrotic disorders

Fibrotic disorders include chronic, debilitating diseases such as:

Liver cirrhosis.
Systemic sclerosis (scleroderma).
Fibrosing lung diseases:

Idiopathic pulmonary fibrosis.
Pneumoconioses.
Drug-induced pulmonary fibrosis.
Radiation-induced pulmonary fibrosis.

End-stage kidney disease.
Constrictive pericarditis.

Because fibrosis is a major cause of morbidity and death in these disorders:

There is great interest in developing anti-fibrotic drugs.

🧠 EXAM REFLEX BLOCK — Factors Impairing Tissue Repair & Abnormal Healing

Use this as instant recall in exams (SBA / viva / short notes).

🔴 TOP CAUSES OF DELAYED HEALING (Think: I-D-N-S-M-P-F-T-L)

Infection → MOST important cause

Prolongs inflammation
Increases tissue injury

Diabetes

Microangiopathy + neuropathy + infection

Nutrition

Protein ↓ → collagen ↓
Vitamin C ↓ → collagen cross-linking ↓

Steroids (Glucocorticoids)

↓ TGF-β → ↓ fibroblasts → weak scars

Mechanical stress

Tension / pressure → dehiscence

Poor perfusion

Arterial (atherosclerosis, diabetes)
Venous (varicose veins)

Foreign bodies

Glass, steel, bone fragments

Type of tissue

Labile/stable → regeneration possible
Permanent cells → inevitable scarring

Location

Large exudates in cavities → organization → fibrosis

🟡 CHRONIC NON-HEALING ULCERS — DIFFERENTIATE FAST

Venous ulcer

Elderly, varicose veins
Hemosiderin pigmentation
Poor oxygen delivery

Arterial ulcer

Atherosclerosis ± diabetes
Ischemia → necrosis
Painful

Pressure sore

Bedridden patients
Pressure + ischemia

Diabetic ulcer

Feet
Ischemia + neuropathy + infection
Histology: epithelial loss + granulation tissue

⚠️ FAILED HEALING COMPLICATION

Dehiscence

Wound rupture
Classically after abdominal surgery
Triggered by ↑ intra-abdominal pressure

🔵 EXCESSIVE REPAIR — KNOW THE NAMES

Hypertrophic scar

Raised, within wound
Regresses with time
Many myofibroblasts

Keloid

Extends beyond wound
Does not regress
Common in African descent

Exuberant granulation (Proud flesh)

Blocks epithelialization
Needs cautery/excision

Desmoid tumor

Aggressive fibromatosis
Recurrent
Gray zone: benign ↔ malignant

🟣 CONTRACTURES

Due to exaggerated wound contraction
Common after burns
Palms, soles, anterior chest
Restrict joint movement

🧬 FIBROSIS — INTERNAL ORGAN SCARRING

Pathologic collagen deposition
Due to persistent injury
Leads to organ dysfunction/failure

⭐ Central mediator:

TGF-β

Triggers:

Necrosis
Apoptosis
ROS

Collagen-producing cells:

Lung/kidney → myofibroblasts
Liver cirrhosis → stellate cells

📌 CLASSIC FIBROTIC DISEASES — MEMORIZE

Liver cirrhosis
Systemic sclerosis
Idiopathic pulmonary fibrosis
Pneumoconioses
Drug / radiation lung fibrosis
End-stage kidney disease
Constrictive pericarditis

🎯 ONE-LINE EXAM LOCK

Delayed healing = infection, ischemia, diabetes, poor nutrition, steroids, tension; excessive healing = hypertrophic scar, keloid, fibrosis driven by TGF-β.

inflammation & repair recall

3.Inflammation & repair

OVERVIEW OF INFLAMMATION – LOGIC-BASED NOTES

1. Definition & Purpose

2. What Inflammation Eliminates

3. Key Defensive Components

4. Core Function of the Inflammatory Process

5. Sequential Steps of Inflammation (Exam Favorite)

6. Types of Inflammation

A. Acute Inflammation

B. Chronic Inflammation

7. Termination of Inflammation

8. Tissue Repair After Inflammation

CAUSES OF INFLAMMATION

1. Infections

2. Tissue Necrosis

3. Foreign Bodies

4. Immune Reactions (Hypersensitivity)

RECOGNITION OF MICROBES & DAMAGED CELLS

1. Cellular Receptors for Microbes

2. Sensors of Cell Damage

3. Circulating Proteins

ACUTE INFLAMMATION — LOGIC-BASED NOTE (ZERO OMISSION)

1. Core Definition & Purpose

2. Three Major Components of Acute Inflammation

3. Sentinel Cell Activation & Mediator Release

4. Vascular Reactions in Acute Inflammation

Overall Goal

Key Process: Exudation

5. Exudate vs Transudate vs Edema vs Pus

6. Changes in Vascular Flow & Caliber

Step-by-Step Sequence

7. Mechanisms of Increased Vascular Permeability

1. Endothelial Cell Retraction (Most Common)

2. Endothelial Injury

3. Transcytosis

8. Lymphatic System Responses

9. Leukocyte Recruitment — Overview

10. Multistep Leukocyte Recruitment Process

11. Leukocyte Adhesion to Endothelium

Hemodynamic Basis

Rolling (Selectins)

Firm Adhesion (Integrins)

12. Leukocyte Adhesion Deficiencies

13. Transmigration (Diapedesis)

14. Chemotaxis

15. Temporal Pattern of Cellular Infiltration

Exceptions

16. Therapeutic Implications

PHAGOCYTOSIS AND CLEARANCE OF THE OFFENDING AGENT

1. Leukocyte Activation – Why It Happens

2. Phagocytosis – The Core Defensive Process

Step 1: Recognition and Attachment

Step 2: Engulfment

Step 3: Killing or Degradation

3. Recognition by Phagocytic Receptors – How Targets Are Identified

3.1 Mannose Receptor

3.2 Scavenger Receptors

3.3 Opsonin Receptors (Most Efficient Pathway)

4. Engulfment – How Particles Are Internalized

5. Intracellular Destruction – How Microbes Are Killed

6. Reactive Oxygen Species (ROS) – Oxygen-Dependent Killing

6.1 Generation of ROS

6.2 Respiratory Burst

6.3 Enzyme Assembly

7. ROS Transformation and Bactericidal Systems

7.1 Hydrogen Peroxide

7.2 Myeloperoxidase (MPO) System

7.3 Hydroxyl Radical

8. Extracellular ROS and Tissue Injury

9. Antioxidant Defense Systems

Key Antioxidants:

10. Clinical Correlation – ROS Deficiency

11. Nitric Oxide (NO) – Nitrogen-Dependent Killing

11.1 NO Synthesis

11.2 iNOS in Macrophages

11.3 Peroxynitrite Formation

11.4 Vascular Effects of NO

12. Granule Enzymes and Antimicrobial Proteins

12.1 Granule Characteristics

13. Neutrophil Granule Types